+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 35383

Chapter 35383 contains a list of PDF Full Texts available from EurekaMag.





Ewald, U.; Farnstrand, C.; Eeg Olofsson, K.E.ebol; Nyqvist, K.H.dberg, 2000:
Neurophysiological registrations of oral behavior during breastfeeding in preterm infants

Mcevoy, L.; Pellouchoud, E.; Smith, M.E.; Gevins, A., 2000:
Neurophysiological signals of working memory in aging

Brustein, E.; Drapeau, P., 1999:
Neurophysiological studies of Diwanka, a zebrafish locomotor mutant

Rusak, B.; Ying, S.W.; Delagrange, P., 1999:
Neurophysiological studies of a novel melatonin receptor antagonist in the rat suprachiasmatic nucleus

Zhang, Y.; Wilbourn, A.J., 1999:
Neurophysiological study of 250 severe carpal tunnel syndrome hands

Tugnoli, V.; Manconi, M.; Quatrale, R.; Eleopra, R.; Gastaldo, E.; Tola, M.R.saria, 2000:
Neurophysiological study of corticomotor pathway in patients with primary Restless Legs Syndrome

Pozzi, A.; Binelli, S.; Franceschetti, S.; Panzica, F.; Scaioli, V.; Avanzini, G., 1999:
Neurophysiological study of the cortical excitability in patients with benign epilepsy with centro-temporal spike

Gottesmann, C., 1999:
Neurophysiological support of consciousness during waking and sleep

Creange, A.; Lefaucheur, J.P.scal, 2003:
Neurophysiological testing of large and small nerve fibers correlates with clinical examination An objective evaluation of sensory neuropathies

Deuschl, G., 1999:
Neurophysiological tests for the assessment of tremors

Dupuis, F.; Lassonde, M.; Lavoje, M.; Gosselin, N.; Johnston, K.M., 1999:
Neurophysiological tools for the evaluation of head injury in elite athletes

Olry, R.; Martinoli, M., 2003:
Neurophysiology and guillotine in Marchioness of CRequis memoirs Dr Segurets experiments on beheaded people

Gray, M.A.; Kemp, A.H.; Silberstein, R.B.; Nathan, P.J., 2002:
Neurophysiology and psychopharmacology of anticipatory anxiety

Drucker Colin, Rene, 1999:
Neurophysiology of habituation and internal inhibition

Foreman, Robert, D., 2000:
Neurophysiology of heart pain

Mears, R.P.; Cromwell, H.C., 2003:
Neurophysiology of inhibitory gating a comparison between single - unit and local field potential responses in rat medial prefrontal cortex

Pillay, S.S.; Rogowska, J.; Kanayama, G.; Jon, D-In.; Gruber, S.; Simpson, N.; Cherayil, M.; Pope, H.G.; Yurgelun-Todd, D.A., 2004:
Neurophysiology of motor function following cannabis discontinuation in chronic cannabis smokers: an fMRI study

Renaud, L.P.; Cui, L.N.; Kolaj, M.; Wang, D., 1999:
Neurophysiology of neuroendocrine responses to humoral, cardiovascular and circadian stressors

Aguggia, M., 2003:
Neurophysiology of pain

Defebvre, L.; Cassim, F., 2003:
Neurophysiology of parkinsonian syndromes

Ruff, R.L., 2003:
Neurophysiology of the neuromuscular junction: overview

Hallett, M., 2001:
Neurophysiology of tics

Poletti, A.; Piccioni, F.; Pinton, P.; Rizzuto, R.; Simeoni, S.; Mancini, M.A.; Seveso, V.; Zanisi, M.; Martini, L., 2000:
Neuropil aggregates of androgen receptor containing an elongated polyglutamine tract block neurite transport in spinobulbar muscular atrophy

Pearson Orange, V.L.; Almond, N.; Luthert, P.J., 1999:
Neuropil derangement revealed by glutamine synthetase immunostaining An early feature of infection by simian immunodeficiency virus

Datwani, A.; Erzurumlu, R.S., 1999:
Neuropilin expression and early neocortical connectivity in sema III knockout mice

Raper, J.A.; Kobayashi, H.; Feiner, L.; Koppel, A.M., 1999:
Neuropilin may be a common component of receptors for secreted semaphorin family members

Xu, F.; Hazzard, T.M.; Scheffler, L.J.; Stouffer, R.L., 2002:
Neuropilin-1 and -2 expression in the monkey corpus luteum during the menstrual cycle

Tuttle, R.; Yano, H.; Chao, M.V.; O'leary, D.D., 2000 :
Neuropilin-1 and Trk exist in a complex regulated by NGF

Ahmad, S.A.if; Liu, W.; Fan, F.; Jung, Y.D.; Reinmuth, N.; Ellis, L.M., 2001:
Neuropilin-1 expression in human colon carcinoma

Sharma, J.; Yan, Y.; Higgins, R.D., 2002:
Neuropilin-1 expression in oxygen induced retinopathy

Liu, W.; Parikh, A.; Stoeltzing, O.; Reinmuth, N.; Fan, F.; Ellis, L.M., 2003:
Neuropilin-1 is upregulated by basic fibroblast growth factor in human vascular smooth muscle cells

Yamada, Y.; Takakura, N.; Fujisawa, H.; Suda, T., 1999:
Neuropilin-1 on nonendothelial cells regulates vasculo-angiogenesis

Fujisawa, H.; Kitsukawa, T.; Shimizu, M.; Hirata, T., 1999:
Neuropilin-1 plays a crucial role in peripheral nerve fiber guidance

Robert, B.; Zhao, J.; Dey, S.K.; Abrahamson, D.R., 1999:
Neuropilin-1, a VEGF isoform-specific coreceptor, is expressed in developing and mature mouse kidney

Resnick, M.B.; Cohen, T.; Neufeld, G.; Greenson, J.K., 2001:
Neuropilin-2 is a novel neuroendocrine marker expressed in pancreatic islet cells and islet cell tumors

Cloutier, J.F.; Giger, R.J.; Koentges, G.; Terman, J.; Dulac, C.; Kolodkin, A.L.; Ginty, D.D., 2001:
Neuropilin-2 is required in vivo for guidance and targeting of vomeronasal neurons

Giger, R.J.; Cloutier, J.F.; Sahay, A.; Prinjha, R.K.; Levengood, D.V.; Moore, S.E.; Pickering, S.; Simmons, D.; Rastan, S.; Walsh, F.S.; Kolodkin, A.L.; Ginty, D.D.; Geppert, M., 2000:
Neuropilin-2 is required in vivo for selective axon guidance responses to secreted semaphorins

Chen, H.; Bagri, A.; Zupicich, J.A.; Zou, Y.; Stoeckli, E.; Pleasure, S.J.; Lowenstein, D.H.; Skarnes, W.C.; Chedotal, A.; Tessier Lavigne, M., 2000:
Neuropilin-2 regulates the development of select cranial and sensory nerves and hippocampal mossy fiber projections

Alitalo, K.; Eriksson, U.; Olofsson, B.; Makinen, T., 2003:
Neuropilin/growth factor complexes and uses thereof

Kolodkin, A.L., 2001:
Neuropilins and the molecular basis of repulsive growth cone guidance

Klagsbrun, M.; Soker, S.; Miao, H.Q.an; Takashima, S., 2003:
Neuropilins and use thereof in methods for diagnosis and prognosis of cancer

Rodriguez, E.R.ne; Dumur, C.I.; Garrett, C.T.; Baldwin, W.M., 2002:
Neuropilins interact with semaphorins and vascular endothelial growth factor in a differential manner in proliferative coronary lesions from atherosclerotic and transplant vasculopathy human arteries

Pan, Q.; Chen, X.; Behm, F.G.; Raimondi, S.C.; Pui, C.H.n; Neale, G.A., 2000:
Neuropilins, ectopically expressed in relapsed childhood acute lymphoblastic leukemia, enhance lymphoid survival and promote tumorigenesis

Logan, E.M.ntreal; Diz, D.I.; Averill, D.B.; Ferrario, C.M.; Ganten, D.; Aileru, A.A., 2002:
Neuroplastic behavior at the ganglion level Comparative studies between 27 and mRen2Lewis models of hypertension

Varga, C.S.; Hoyk, Z.S.; Morin, F.; Wolff, J.R.; Parducz, 2000:
Neuroplastic changes in the glomeruli of the rat olfactory bulb induced by chemical deafferentation

Murphy, K.J.; Lynch, M.A.; Regan, C.M., 2001:
Neuroplastic events required for LTP and avoidance learning are impaired by opiate addiction

Thompson, C.K., 2000:
Neuroplasticity: evidence from aphasia

Van Den Oever, M.C.; Spijker, S.; D.V.ies, T.J.; Schoffelmeer, A.N.M.; Smit, A.B., 2003:
Neuroplasticity at the synapse Persistent changes in gene expression resulting from heroin and natural reward

Mesulam, M.M., 1999:
Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles

Jakowec, M.W.; Fisher, B.; Nixon, K.; Hogg, E.; Meshul, C.; Bremmer, S.; Mcneill, T.; Petzinger, G.M., 2003:
Neuroplasticity in the MPTP-lesioned mouse and nonhuman primate

Tillakaratne, N.J.; D.L.on, R.; Joynes, R.; Bigbee, A.; London, N.; Sebata, H.S.; Lo, C.Y.; Roy, R.R.; Edgerton, V.R.; Tobin, A.J., 2000:
Neuroplasticity of sensory, motor and interneurons in neonatally spinal transected rats after robotically assisted-locomotor training

Keith, I.M.; Bisgard, G.E., 1999:
Neuroplasticity of the hypoxic ventilatory response after prolonged dopaminergic or hypoxic stimulation

Beesley, P.W.; Shabir, S.; Khanzada, U.; Langnaese, K.; Smalla, K.H.; Mummery, R.; Gundelfinger, E.D., 2000:
Neuroplastin 65 and 55 Characterisation of homophilic adhesive interactions

Kitahara, Y.; Takesue, K.; Miura, K.; Takeda, T.; Hirose, K.; Suzuki, K.; Kihara, H., 2003:
Neuropreotective effect of AT-1015, a novel 5-HT2A antagonist on experimental diabetic neuropathy

Mills, R.H.; Sinchak, K.; Mann, D.; Martinez, D.; Wright, R.; Micevych, P., 2003:
Neuroprogesterone regulation of female reproductive behavior

Hunter, Jackie, 1999:
Neuroprotectant agents and stroke High-risk or golden opportunity?

Cortina, M.Soledad.; He, J.; Li, N.; Bazan, N.G.; Bazan, H.E.P., 2010:
Neuroprotectin D1 synthesis and corneal nerve regeneration after experimental surgery and treatment with PEDF plus DHA

Slikker, W., J.; Jonas, S.; Auer, R.N.; Palmer, G.C.; Narahashi, T.; Youdim, M.B.H.; Maynard, K.I.; Carbone, K.M.; Trembly, B., 2001:
Neuroprotection Past successes and future challenges

Virno, M.; Pannarale, L., 1999:
Neuroprotection Role of the antiglaucomatous treatment

Chuang, D.Maw, 2002:
Neuroprotection against apoptosis What has it got to do with lithium, a mood stabilizing drug

Law, A.; Gauthier, S.; Quirion, R., 2000:
Neuroprotection against beta-amyloid toxicity by nitric oxide synthase inhibitors

Borsello, T.; Vercelli, A.E.; Hirt, L.; Repici, M.; Bonny, C.; Clarke, P.G.H., 2003:
Neuroprotection against cerebral ischemia by a peptide inhibitor of c - Jun N - terminal kinase action

Clarke, P.G.H.; Hirt, L.; Vercelli, A.; Repici, M.; Bonny, C.; Hornung, J.P.; Croquelois, K.; Borsello, T., 2003:
Neuroprotection against excitotoxicity and ischemia using cell-permeable peptides that inhibit JNK action

Savaskan, N.E.; Braeuer, A.U.; Ninnemann, O.; Nitsch, R., 2001:
Neuroprotection against glutamate-induced toxicity by selenium

Schipma, M.J.; Neafsey, E.J.; Collins, M.A., 2003 :
Neuroprotection against gp120 by moderate ethanol pre - conditioning evidence for a chemokine receptor - mediated mechanism

Koenig, M.L.; Yourick, D.L.; Ma, L.; Hsia, C.J.; Long, J.B., 2000:
Neuroprotection against hemoglobin-induced oxidative injury in vitro by polynitroxylated compounds and free nitroxides

Bickler, P.E.; Fahlman, C.S.; Schuyler, J., 2002:
Neuroprotection against oxygen/glucose deprivation by elevating intracellular calcium in hippocampal slice cultures

Nambiar, M.P.; Tetz, L.M.; Doctor, B.P.; Gordon, R.K., 2004:
Neuroprotection against seizure/status epilepticus induced by lithium-pilocarpine using new generation anti-epileptic drugs

Jeng, W.; Wells, P.G., 2003:
Neuroprotection against stereoselective 3, 4-methylenedioxymethamphetamine -initiated oxidative stress and DNA damage in prostaglandin H synthase-1 knockout mice

Stankoff, B.; Noel, F.; Demerens, C.; Zalc, B.; Lubetzki, C., 1999:
Neuroprotection and central nervous system myelination New prospects for multiple sclerosis?

Acarin, L.; Gonzalez, B.; Castellano, B., 2001:
Neuroprotection and downregulation of the glial response and inflammatory molecules by triflusal post-treatment after excitotoxic damage to the postnatal brain

Malhotra, A.D.; Geocadin, R.G.; Tong, S.; Bezerianos, A.; Hanley, D.F.; Thakor, N.V., 2002:
Neuroprotection and injury severity correlate with entropy EEG measures in a cardiac arrest model

Tortella, F.C.; Williams, A.; Hale, S.; Elliott, P., 2001:
Neuroprotection and ischemic brain injury in rats Improved therapeutic window obtained with the proteasome inhibitor PS-519

Payan, C.A.M.; Viallet, F.; Lacomblez, L.; Graf, M.; Landwehrmeyer, B.; Borg, M.; Durif, F.; Fermanian, J.; Agid, Y.; Ludolph, A.C.; Leigh, P.N.; Bensimon, G.; Nnipps Study Group, 2003:
Neuroprotection and natural history in Parkinson Plus Syndromes Construction and validation of a clinical scale to assess disease progression in progressive supranuclear palsy and multiple system atrophy

Kraft, E.; Jarosz, J.; Verin, M.; Deasy, N.; Rolland, Y.; Hauser, T.K.; Delmaire, C.; Defebvre, L.; Payan, C.; Ludolph, A.C.; Leigh, N.P.; Bensimon, G.; Nnipps Study Group, 2003:
Neuroprotection and natural history in Parkinson plus syndromes Cross-sectional description of magnetic resonance imaging findings in a large prospective cohort of patients with progressive supranuclear palsy and multiple system atrophy

Verin, M.; Rolland, Y.; Defebvre, L.; Delmaire, C.; Payan, C.; Nnipps Study Group, 2003:
Neuroprotection and natural history in Parkinson plus syndromes Preliminary results of the magnetic resonance imaging study in progressive supranuclear palsy and multiple system atrophy

Gremo, F.; Scintu, F.; Reali, C.; Curto, M.; Sogos, V., 2001:
Neuroprotection and neurodegeneration Effects of S-100 and trimethyltin in human microglia

Destée, A., 2003:
Neuroprotection and neurodegenerative parkinsonian syndromes

Tortella, F.C.; Britton, P.; Williams, A.; May Lu, X.C.ung; Newman, A.H., 1999:
Neuroprotection and neurotoxicity studies in rats with AHN649, a 3-amino analog of dextromethorphan and low-affinity N-methyl-D-aspartate antagonist

Rajendra, W.; Armugam, A.; Jeyaseelan, K., 2004:
Neuroprotection and peptide toxins

Privat, A.; Gaviria, M.; Gimenez, M.; Ribotta, Y., 2000:
Neuroprotection and regeneration in spinal cord injury

Cho, S.; Park, E.M.; Cho, B.P.; Cruz, M.O.; Joh, T.H., 2001:
Neuroprotection and repressed microglia activation by ibuprofen after transient forebrain ischemia in rat

Garry, D.J.; Mammen, P.P.A., 2003:
Neuroprotection and the role of neuroglobin

Faden, A.I., 2002:
Neuroprotection and traumatic brain injury: theoretical option or realistic proposition

Karunanithi, S.; Barclay, J.W.; Brown, I.R.; Robertson, R.M.; Atwood, H.L., 1999:
Neuroprotection at the Drosophila synapse is enhanced in transgenic animals overexpressing heat shock protein hsp70

Yang, Y.; Li, Q.; Shuaib, A., 2000:
Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone and N-tert-butyl- -nitrone , in rats subjected to focal embolic cerebral ischemia

Demerle Pallardy, C.; Roubert, V.; Marin, J.G.; Auguet, M.; Chabrier, P.E., 1999:
Neuroprotection by BN 80933 against oxidative stress on a mouse hippocampal cell line and hypoxia on primary cortical neuronal cultures

Marcheselli, V.; Tian, X.; Thompson, H.; Bazan, N.G., 2000:
Neuroprotection by BN-50730 in the stroke model of mouse middle cerebral artery occlusion

Bergamaschini, L.; Barba, M.; Catapano, L.; Storini, C.; D.L.igi, A.; Rossi, E.; Arabia, A.M.; D.S.moni, M.G., 2001:
Neuroprotection by C1 inhibitor in a mouse model of transient and focal brain ischemia

Sheng, H.; Srinivasan, S.; Logsdon, C.; Wiley, J.W.; Hall, K.E., 1999:
Neuroprotection by C2 ceramide in aging is independent of NFkappaB activation

Watanabe, Y.; Cui, Y.L.; Takamatsu, H.; Kakiuchi, T.; Kataoka, Y.; Satoh, T.; Watanabe, Y.; Hosoya, T.; Suzuki, M.; Tsukada, H., 2000:
Neuroprotection by CNS-type prostacyclin receptor agonists in MCAO-reperfusion models of gerbils and monkeys

Kurth, C.D.an; Priestley, M.; Watzman, H.M.; Mccann, J., 2002:
Neuroprotection by Desflurane during Deep Hypothermic Circulatory Arrest

Messmer, K.; Matthews, C.C.; Parks, D.; Remington, M.; Bowen, T.; Oyler, G.A.; Fishman, P.S., 2003:
Neuroprotection by GPT and GPT - TTC in spinal cord

Grigore, A.M.; Nussmeier, N.A.; Thong, W.Y.; Moore, J.A.; Vaughn, W.K., 2002:
Neuroprotection by High Dose Magnesium in CABG Patients Preliminary Data

Nakatsuka, D.; Satoh, T.; Tanaka Nakadate, S.; Watanabe, Y.; Nagata, I.; Kikuchi, H.; Namura, S., 2000:
Neuroprotection by MEK inhibition with U0126 against oxidative stress

Palmer, G.C., 2001:
Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies

Kato, H.; Araki, T.; Mikami, T.; Imai, Y.; Mizugaki, M.; Takahashi, A.; Itoyama, Y., 2000:
Neuroprotection by ONO-2506 in the MPTP-mouse model of Parkinsons disease

Tian, X.; Marcheselli, V.L.; Bazan, N.G., 2003:
Neuroprotection by PAF-receptor antagonists against brain damage induced by cerebral ischemia - reperfusion

Galoyan, A.A.; Sarkissian, J.S.; Kipriyan, T.K.; Sulkhanyan, R.M.; Abrahamyan, S.S.; Sarkissian, E.J.; Meliksetyan, I.B.; Chavushyan, E.A.; Grigorian, Y.K.H., 2001:
Neuroprotection by PRP

Bar Joseph, A.; Lavie, V.; Berckovitch, Y.; Weksler, A.; Azulay, M.; Grienstein, Y.; Fink, G., 2001:
Neuroprotection by PRS-211,095 Assessed functionally and morphologically in transient MCA occlusion in rats

Lee, L.L.; Muizelaar, J.P.; Lyeth, B.G.; Berman, R.F., 2000:
Neuroprotection by SNX-185, an N-type calcium channel blocker, in a rat LFP brain injury model

Kim, H.; Lee, J.; Park, K.Y.; Cho, K.; Lim, B.O.; Suk, K.; Kim, S.Y.; Shin, J.S.; Ahn, D.K., 2000:
Neuroprotection by Uncaria rhynchophylla against global cerebral ischemia in rat inhibition of microglial TNF-alpha and nitric oxide production

Goerlach, C.; Hortobagyi, T.; Hortobagyi, S.; Benyo, Z.; Relton, J.K.; Whalley, E.T.; Wahl, M., 2000:
Neuroprotection by a bradykinin B2 receptor antagonist after traumatic brain injury is not attenuated by the simultaneous application of a bradykinin B1 receptor antagonist

Bar Joseph, A.; Lavie, V.; Berckovitch, Y.; Azulay, M.; Weksler, A.; Grienstein, Y.; Garzon, A.; Greenberg, O.; Elgamiel, R.; Amselem, S.; Fink, G., 2002:
Neuroprotection by a dextrocannabinoid in a 3 hours therapeutic window assessed functionally in transient mca occlusion in rats

Torup, L.; Villa, P.; Ghezzi, P.; Cerami, A.; Brines, M.; Sager, T., 2003:
Neuroprotection by a non - erythropoietic erythropoietin in a model of focal cerebral ischemia in rats

Ghezzi, P.; Bianchi, R.; Brines, M.; Latini, R.; Leist, M.; Sager, T.; Torup, L.; Villa, P.; Cerami, A., 2003:
Neuroprotection by a non-erythropoietic derivative of erythropoietin

Brywe, K.G.; Isgaard, J.; Mallard, C.; Gustafson, M.; Blomgren, K.; Hagberg, H., 2003:
Neuroprotection by a novel GH-releasing peptide following Hypoxic-Ischemic brain injury in neonatal rats

Grider, M.H.; Mamounas, L.A.; Baumgartner, B.J.; Shine, H.D., 2001:
Neuroprotection by adenoviral-mediated expression of brain-derived neurotrophic factor

Yamamoto, T.; Yuyama, K.; Kato, T.; Sora, I.; Yamamoto, H., 2000 :
Neuroprotection by ascorbic acid on nitric oxide -induced cell death

Liu, C.; Wu, J.; Xu, K.; Cai, F.; Gu, J.; Ma, L.; Chen, J., 2010:
Neuroprotection by baicalein in ischemic brain injury involves PTEN/AKT pathway

Azcoitia, I.; Sierra, A.; Veiga, S.; Chowen, J.A.; Garcia Segura, L.M., 2000:
Neuroprotection by brain aromatase

D.S.moni, M.G.; Barba, M.; Storini, C.; Catapano, L.; Arabia, A.M.; Perego, C.; Deluigi, A.; Bergamaschini, L., 2001:
Neuroprotection by complement C1 inhibitor in mouse transient brain ischemia

Lim, B.O.; Kim, H.; Kim, S.Y.; Suk, K.; Kim, Y.S.; Cho, K.; Hur, J.; Park, J.; Park, S.Y.; Park, C.W.; Shoyama, Y.; Leem, K., 2001:
Neuroprotection by crocin, an inhibitor of lipid peroxidation, against brain ischemia induced by four-vessel occlusion in rats

Ballough, G.P.; Forster, J.S.; Jaworski, M.J.; Jaworski, J.M.; Filbert, M.G., 2000:
Neuroprotection by dexanabinol following nerve agent-induced seizures determination of the therapeutic window

Aruoma, O.I., 2003:
Neuroprotection by dietary antioxidants: new age of research

Zhu, Yuan; Krieglstein, Josef, 2003:
Neuroprotection by drug-induced growth factors

Garcia Segura, L.M.guel; Azcoitia, I.; Doncarlos, L.L., 2001:
Neuroprotection by estradiol

Garcia Segura, L.M.guel; Doncarlos, L.L.; Azcoitia, I., 2002:
Neuroprotection by estradiol Role of brain aromatase and interaction with insulin-like growth factor-I signaling

Bhatt, S.D.; Guo, Q., 2002:
Neuroprotection by estrogen in prostate apoptosis response 4 overexpressing pc12 cells

Watanabe, Y.; Kuroki, Y.; Nishio, M., 2001:
Neuroprotection by estrogen is possibly mediated partly through a novel estrogen receptor in the rat hippocampus

Kim, H.; Kim, S.Y.; Suk, K.; Leem, K.; Kim, Y.O.; Jeong, S.; Baek, J.; Lee, K.; Lee, J.; Lee, P., 2001:
Neuroprotection by extracts of Scutellaria baicalensis, a medicinal herb Effects of individual fractions and compounds isolated from the herb

Phillis, J.W., 2002:
Neuroprotection by free radical scavengers and other antioxidants

Martins, R.A.P.; Police, A.I.S.; Linden, R., 2002:
Neuroprotection by glutamate in developing retina regulation of neurotrophin expression and intracelular signaling pathways

Sugiyama, C.; Yoneda, Y., 2004:
Neuroprotection by group II mGluR in primary cultured rat cortical neurons

Heyburn, J.W.; Bramlett, D.R.; Gonzales, C.; Xiao, Y.; Zaleska, M.M., 2001:
Neuroprotection by inhibition of reversed glutamate transport in malonate induced excitotoxicity in rats

Xu, K.; Xu, Y.H.; Chen, J.F.; Schwarzschild, M.A., 2002:
Neuroprotection by metabolites of caffeine may prolong its neuroproctective effect in the mptp model of pd

Tabakman, R.; Lecht, S.; Lazarovici, P., 2003:
Neuroprotection by monoamine oxidase B inhibitors: a therapeutic strategy for Parkinson's disease?

Abraini, J.H.; David, Hélène.N.; Nicole, O.; MacKenzie, E.T.; Buisson, A.; Lemaire, M., 2004:
Neuroprotection by nitrous oxide and xenon and its relation to minimum alveolar concentration

Liu, W.G.; Chen, S.D.; Chen, Y., 2004:
Neuroprotection by pergolide against levodopa-induced

Morali, G.; Gonzalez Vidal, M.D.; Escobar, A.; Cervantes, M., 2001:
Neuroprotection by progesterone on caudate nucleus damage elicited by acute global cerebral ischemia in cats

Naoi, M.; Maruyama, W.; Akao, Y.; Yi, H.; Youdim, M.B.H., 2002:
Neuroprotection by rasagiline and related compounds

Arendt, T.; Holzer, M.; Gaertner, U.; Ueberham, U.; Brueckner, M.K., 2000:
Neuroprotection by repressing G0-G1 transition A therapeutic strategy for AD?

Le, D.A.; Wang, Y.; Kaul, M.; Lipton, S.A., 1999:
Neuroprotection by salicylhydroxamic acid is in part mediated by scavenging free-radicals

Clausen, F.; Ebendal, T.; Hillered, L., 2001:
Neuroprotection by the MEK-inhibitor U0126 given after experimental traumatic brain injury

Chun, H.S.ok; Choi, E.H.e; Chang, H.J.o; Kim, J.M.ung; Kim, W.K.; Chang, N., 2004:
Neuroprotection by the aromatic extract isolated from Pinus densiflora on the in vitro and in vivo ischemic damage

Jork, R.; Gerlach, I.; Horvath, E., 2000:
Neuroprotection by the novel 5-HT1A receptor agonist BAY X 3702 in rodent models of cerebral ischemia and traumatic brain injury

Araujo, D.M.; Song, D.; Zivin, J.A.; Lapchak, P.A., 2001:
Neuroprotection by the selective cyclooxygenase -2 inhibitor SC-236 results in improvements in ischemia-induced behavioral deficits

Marcheselli, V.L.; Decoster, M.A.; Campbell, Z.; Barreiro, S.G.; Bazan, N.G., 2001:
Neuroprotection by unoprostone, but not by latanoprost, against glutamate-stimulated calcium influx and cell death in retinal ganglion cells

Whitaker, D.C.; Stygall, J.; Newman, S.P., 2002:
Neuroprotection during cardiac surgery: strategies to reduce cognitive decline

Haghparast, A.; Ghambar Nejad, A., 2003:
Neuroprotection effect of kynurenate in the CA1 and CA3 regions of the hippocampus following experimental brain injury in the rat

Olanow, C.Warren.; Schapira, A.H.V.; Agid, Y., 2003:
Neuroprotection for Parkinson's disease: prospects and promises

Voznyuk, I.A.; Odinak, M.M.; Yanishevsky, S.N.; Onistchenco, L.S., 2003:
Neuroprotection for acute ischemic damage with ALFA-GPS

Liebeskind, D.S.; Kasner, S.E., 2001:
Neuroprotection for ischaemic stroke: an unattainable goal?

Andrews, R.J., 2001:
Neuroprotection for the new millennium. Matchmaking pharmacology and technology

Mackensen, G.B.; Patel, M.; Crapo, J.D.; Batinic Haberle, I.; Warner, D.S., 2002:
Neuroprotection from Delayed Post-Ischemic Administration of a Metalloporphyrin Catalytic Antioxidant in the Rat

Park, E.M.; Cruz, M.O.; Chu, C.K.; Song, G.Y.; Joh, T.H.; Cho, S., 2001:
Neuroprotection from ischemia-induced cell death via MAP kinase-dependent CREB phosphorylation

Cho, S.; Park, E.M.; Cruz, M.; Chu, C.K.; Joh, T.H., 2000:
Neuroprotection from staurosporin-induced apoptosis by MAP kinase-dependent CREB phosphorylation

Lahousen, T.; Bonelli, R.M., 2003:
Neuroprotection in Hungtingtons disease

Olsson, T.L.; Hansson, O.; Nylandsted, J.; Jttela, M.; Wieloch, T.; Smith, M.L., 2002:
Neuroprotection in a mouse model of global cerebral ischemia by mk 801 but not by overexpression of hsp70i

Reynolds, J.N.; Bennett, B.M.; Jhamandas, K.; Boegman, R.J.; Thatcher, G.R.J., 1999:
Neuroprotection in a rat model of focal cerebral ischemia by a novel family of nitrate esters

Baron, J.C., 2003:
Neuroprotection in acute ischaemic stroke Challenges and prospects

Schaller, B., 2003:
Neuroprotection in brain tumors Pathophysiological sense or nonsense?

Moonen, J.; Bogaert, L.; O'neill, M.J.; Ebinger, G.; Michotte, Y., 2000:
Neuroprotection in cerebral ischemia The role of L-type and N/P/Q-types of voltage sensitive calcium channel blockers

Ives, J.; Jonas, W.; Hartings, J.; Olufade, A.; Williams, A.; Eagles, D.; Tortella, F., 2001:
Neuroprotection in experimental rat brain injury with ultra high dilution glutamate but not potassium chloride

Reichmann, H., 2003:
Neuroprotection in idiopathic Parkinson's disease

Ehrenreich, H.; Siren, A.L., 2003:
Neuroprotection in neuropsychiatric disease

Osborne, N.N.; Ugarte, M.; Chao, M.; Chidlow, G.; Bae, J.H.; Wood, J.P.; Nash, M.S., 1999:
Neuroprotection in relation to retinal ischemia and relevance to glaucoma

Pardridge, W.M.., 2001:
Neuroprotection in stroke: is it time to consider large-molecule drugs?

Azcoitia, I.; Sierra, A.; Chowen, J.; Garcia Segura, L.M., 1999:
Neuroprotection in the adult rat hippocampus Interaction of estrogen receptors and IGF-I receptor signaling

Spedding, M.; Evrard, P.; Gressens, P., 2001:
Neuroprotection in the newborn infant: interactions between stress, glutamate, glucocorticoids and development

Harvey, B.K.; Luo, Y.; Chen, S.; Hoffer, B.J.; Federoff, H.J.; Wang, Y., 2002:
Neuroprotection induced by bmp 7 protein and herpes amplicon vectors expressing bmp 7 involves map kinase signaling in primary cortical culture

Blaabjerg, M.; Fang, L.; Zimmer, J.; Baskys, A., 2002:
Neuroprotection induced by group i metabotropic glutamate receptors is associated with decreased nmda stimulated currents

Bonastre, M.; Marin, C.; Saldana, M.; Aguilar, E.; Tolosa, E., 2002:
Neuroprotection induced by sodium salicylate in 6 ohda lesioned rats is not associated to modification of nigral bax expression

Chiarini, L.B.; Freitas, A.R.O.; Martins, V.R.; Brentani, R.R.; Linden, R., 2000:
Neuroprotection mediated by the cellular prion protein

Semkova, I.; Krieglstein, J., 1999:
Neuroprotection mediated via neurotrophic factors and induction of neurotrophic factors

Urayama, A.; Yamada, S.; Kimura, R.; Zhang, J.; Watanabe, Y., 2002:
Neuroprotection of C57BL/6J mouse brain ischemia by taltirelin, a novel thyrotropin-releasing hormone analogue

Park, J.Y.ung; Kwon, K.J.; Jung, Y.S.ok; Moon, C.H.un; Lee, S.H.an; Baik, E.J.o, 2004:
Neuroprotection of Fructose-1,6-bisphosphate on NMDA-increased ROS via p38 MAPK/ERK in pure cortical neuron

Velly, L.; Guillet, B.; Pisano, P.; Bruder, N.; Gouin, F., 2002:
Neuroprotection of Propofol during an In Vitro Cerebral Ischemia Glutamate Transporters Are a Major Target

Proescholdt, M.; Heimann, A.; Kempski, O., 2001:
Neuroprotection of S(+) ketamine isomer in global forebrain ischemia

Fisher, Marc, 1999:
Neuroprotection of acute ischemic stroke Where are we?

Lo, A.C.; Black, J.A.; Waxman, S.G., 2003:
Neuroprotection of axons in experimental allergic encephalomyelitis with a sodium channel blocking agent

Le, D.A.; Huang, Z.; Kuida, K.; Moskowitz, M.A., 2001:
Neuroprotection of caspase-3 deficient neuronal cultures against oxygen-glucose deprivation

Wagner, B.P.; Nedelcu, J.; Adcock, K.; Loenneker, T.; Martin, E., 2002:
Neuroprotection of creatine supplementation in neonatal rats with transient hemispheric cerebral hypoxia-ischemia

Kuroki, Y.; Kanda, Y.; Mizuno, K.; Nishio, M.; Watanabe, Y., 2001:
Neuroprotection of estrogen is mediated both through a nuclear estrogen receptor-dependent pathway and through another pathway via extracellular signal-regulated kinase in the rat hippocampus

Kakuda, T.; Nozawa, A.; Kubo, T.; Tsukamoto, S., 2001:
Neuroprotection of gamma-glutamylethylamide against kainic acid toxicity in rat hippocampus

Kakuda, T.; Yanase, H.; Luo, J.; Nozawa, A.; Unno, T.; Kataoka, K., 2000:
Neuroprotection of gamma-glutamylethylamide in middle cerebral artery occlusion in the rat

Manoonkitiwongsa, P.S.; Schultz, R.L.; Mccreery, D.B.; Whitter, E.F.; Lyden, P.D., 2004:
Neuroprotection of ischemic brain by VEGF is critically dependent on proper dosage and may be compromised by angiogenesis

Zhang, H.; Tong, E.T., 2002:
Neuroprotection of mild hypothermia beginning at different time intervals on cerebral ischemia/reperfusion injury

Oiwa, Y.; Sanchez Pernaute, R.; Nakai, K.; Itakura, T.; Bankiewicz, K.S., 2000:
Neuroprotection of neurturin in parkinsonian rats with extensive dopaminergic terminal lesion

Gordon, W.C.; Gershanik, E.; Casey, D.; Bazan, N.G., 2000:
Neuroprotection of photoreceptors during light-induced damage by a PAF receptor antagonist

Gao, T.M.; Huang, H.; Gong, L.W.; Li, X., 2000:
Neuroprotection of potassium channel blocker TEA on hippocampal CA1 pyramidal neurons following transient forebrain ischemia in rats

Sabelhaus, C.F.; Schroeder, U.H.; Breder, J.; Henrich Noack, P.; Scheich, H.; Reymann, K.G., 2000:
Neuroprotection of the group III mGluR agonist -phosphonophenylglycine against hypoxic/hypoglycemic injury in rat hippocampal slices

Schwartz, M.; Moalem, G.; Fisher, J.; Yoles, E., 2000:
Neuroprotection of the injured optic nerve by vaccination to self-myelin peptides

Husson, I.; Mesples, B.; Gressens, P., 2001:
Neuroprotection of the newborn brain by systematic administration of melatonin

Slikker, W.; Duhart, H.; Gaylor, D.; Imam, S., 2003:
Neuroprotection or neurotoxicity: impact of discontinuous dose-response curves on risk assessment

Brennan, C.; Roubin, G.S.; Iyer, S.S.; Mgaieth, S.; Kumar, P.; A.M.barak, N.; Mehran, R.; Dangas, G.; Leon, M.B.; Vitek, J.J.; New, G., 2002:
Neuroprotection reduces the risk of peri-procedural major strokes and death in octogenarians

Personett, D.A.; Williams, K.; Baskerville, K.; Mckinney, M., 2002:
Neuroprotection systems in cholinergic neuron like cells

Sakaguchi, T.; Kuno, M.; Kawasaki, K., 2000:
Neuroprotection through blockade of NMDA receptors by gluconate in hippocampal organotypic cultures

Chen, S.D.; Liu, W.G.; Lu, G.Q.; Li, B., 2004:
Neuroprotection through delivery of neurturin by C172 neural stem cells in a rat model of PAR

Chicoine, L.M.; Bahr, B.A., 2003:
Neuroprotection through polysaccharide modulation of AMPA receptors

Furukawa, S.; Nitta, A., 2002:
Neuroprotection through the stimulation of neurotrophin synthesis

Mueller Velten, R.; Lagreze, W.; Feuerstein, T., 2000:
Neuroprotection with Gabapentin-Lactam in retinal ischemia Dose-effect relationship in postischemic treatment

Wallis, R.A.; Panizzon, K.L.; Shin, D., 2002:
Neuroprotection with caspase-9 inhibition against in vitro and in vivo trauma

Lawrence, E.J.; Neumar, R.W., 2003:
Neuroprotection with four - hour delayed hypothermia after simulated global brain ischemia

Planas, A.M.; Justicia, C.; Friguls, B.; Petegnief, V., 2002:
Neuroprotection with growth factors and intracellular signaling in focal cerebral ischemia

Dell, C.P.; Murray, T.K.; Swettenham, J.B.; Hicks, C.A.; Ward, M.A.; Winny, C.; O'neill, M.J., 2000:
Neuroprotection with neuronal nitric oxide synthase inhibitors in a model of Parkinsons disease in rats

Fahlman, C.S.; Schuyler, J.A.; Bickler, P.E., 2003:
Neuroprotection with the anesthetic isoflurane depends on MAP kinase mek1/2

Schlieter, M.; Li, H.; Mueller, B.K.; Riepe, M.W., 1999:
Neuroprotection with ticlopidin and other inhibitors of platelet aggregation

Cha, B.H.; Silveria, D.C.; Liu, X.; Holmes, G.L., 2001:
Neuroprotection with topiramate following recurrent neonatal seizures

Chenard, B.L.; Butler, T.W., 2000:
Neuroprotective 3- -chroman-4,7-diol and 1- -2- -alkanol derivatives

Sawada, A.; Karim, M.Z.; Mizuno, K.; Kawakami, H.; Yamamoto, T., 2002:
Neuroprotective Action of Nipradilol in a Rat Model of Optic Nerve Degeneration

Garg, S.; Sanchez, R.N.; Chu, Q.; Lam, T.T., 2002:
Neuroprotective Effect Of NS-398, A Cyclooxygenase 2 Inhibitor, On Retinal Ischemia-Reperfusion Injury In Rats

Woldemussie, E.; Craft, D.K.; Wheeler, L.A., 2002:
Neuroprotective Effect of Different Formulations of Topically applied Brimonidine after Calibrated Optic Nerve Injury

Zhen, W.; Yuke, T.; Chuanhan, Z.; Peng, W., 2003:
Neuroprotective Effect of Hemodilution Preconditioning with Hydroxyethyl Starch 200/05 on Global Cerebral Ischemia in Rats

Lei, B.; Kass, I.S.; Cottrell, J.E., 2002:
Neuroprotective Effect of Low-Dose Lidocaine in a Rat Model of Transient Focal Cerebral Ischemia

Sebag, J.; Garg, S.; Tong, L.; Sadun, A.A.; Ma, L.; Lam, T.T., 2002:
Neuroprotective Effect of a TOPS-ester on Retinal Ischemia-Reperfusion Injury

Morimoto, T.; Miyoshi, T.; Sawai, H.; Inoue, T.; Fujikado, T.; Tano, Y.; Fukuda, Y., 2002:
Neuroprotective Effects of Electrical Stimulation on the Axotomized Retinal Ganglion Cells in Vivo

Nucci, C.; Piccirilli, S.; Nistico, R.; Cerulli, L.; Bagetta, G., 2002:
Neuroprotective Effects of Intravitreal Tetanus Neurotoxin Injection in the Lateral Geniculate Nucleus of Monocularly Deprived New-Born Rats

Schmidt, M.; Marx, T.; Schirmer, U., 2003:
Neuroprotective Effects of Xenon Attenuate Reperfusion Damage after Cerebral Ischemia

Matsumoto, Y.; Sawaguchi, S.; Bernstein, S.L., 2002:
Neuroprotective Efficacy of Different Drug Classes on a Rodent Model of Ischemic Optic Neuropathy

Lockhart, B.; Favale, D.; Villain, N.; Roger, A.; Gandon, M.H.; Dorey, G.; Casara, P.; Lestage, P., 1999:
Neuroprotective action of S33113-1, a new dihydroquinoline derivative with antioxidant properties

Manning Bog, A.B.; Mccormack, A.L.; Purisai, M.; Cumine, S.; D.M.nte, D.A., 2003:
Neuroprotective action of alpha - synuclein in transgenic mice

Schmidt, W.; Striggow, F., 2003:
Neuroprotective action of poly polymerase inhibitors on infarct volume after transient focal cerebral ischemia in rats

Hong, S.B.; Kang, H.J.; Choi, Y.S.; Won, S.J.; Gwag, B.J.; Lee, H.W., 2001:
Neuroprotective action of the catalytic subunit of telomerase through prevention of N-methyl-D-aspartate-induced calcium accumulation

Muralikrishnan, D.; Ebadi, M., 1999:
Neuroprotective actions of -SKF-38393 HCl, a dopamine1 receptor agonist in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine -induced Parkinsonism

Sharma, S.K.; Carlson, E.C.; Ebadi, M., 2004:
Neuroprotective actions of Selegiline in inhibiting 1-methyl, 4-phenyl, pyridinium ion -induced apoptosis in SK-N-SH neurons

Ebadi, M.; Sharma, S., 2003:
Neuroprotective actions of coenzyme Q10 and metallothionein in Parkinsons disease

Mandel, S.; Levites, Y.; Weinreb, O.; Youdim, M.B.H., 2002:
Neuroprotective actions of green tea polyphenol, -epigallocatechin-3-gallate in models of Parkinsons disease Gene targets

Hashimoto, R.; Hough, C.; Kanai, H.; Hiroi, T.; Chuang, D.M., 2001:
Neuroprotective actions of lithium against excitotoxicity in rat cerebral cortical neurons

Taylor, M.D.; Ryals, J.M.; Wright, D.E., 2002:
Neuroprotective actions of nt 3 on adult muscle afferent drg neurons

Drobitch, R.; Van Kampen, J.M.; Robertson, H.A.; Hagg, T., 2001:
Neuroprotective actions of the ginseng extract G115 in a rodent model of Parkinsons disease

O'shea, R.D.; Fodera, M.V.; Aprico, K.; Beart, P.M., 2000:
Neuroprotective actions of the glutamate transport inhibitor -2- glycine in organotypic hippocampal cultures of the rat

Srinivasan, D.M.; Pass, L.A.; Hopkins, D.A.; Scheff, S.W.; Pauly, J.R., 2003:
Neuroprotective actions of the nicotinic receptor antagonist methyllycaconitine following experimental brain injury

Schabitz, W.; Gumbel, C.; Spielvogel, D.; Sommer, C.; Pitzer, C.; Gassler, N.; Schwaninger, M.; Kollmar, R.; Krupp, E.; Schwab, S.; Schneider, A., 2003:
Neuroprotective activities of G - CSF are mediated by activation of STAT3 in neurons

Gil Ad, I.; Shtaif, B.; Offen, D.; Melamed, E.; Weizman, A., 2000:
Neuroprotective activity of IGF-1 against dopamine and doxorubicin - induced apoptosis in different neuronal cultures

Wang, C-Kwe.; Chen, L-Geeng.; Wen, C-Luan.; Hou, W-Chi.; Hung, L-Fang.; Yen, S-Jung.; Shen, Y-Jyun.; Lin, S-Yi.; Liang, Y-Chih., 2010:
Neuroprotective activity of Vitis thunbergii var. taiwaniana extracts in vitro and in vivo

Kalapesi, F.B.; Hill, M.A.; Coroneo, M.T., 2003:
Neuroprotective agent brimonidine a toxicity study

Palanki, M.S.S.; Bhagwat, S.S.; Sato, H.; Erdman, P.E.; Doubleday, M., 2002:
Neuroprotective agents and methods related thereto

Namil, A.; Hellberg, M.R., 2001:
Neuroprotective agents having antioxidant and NMDA antagonist activity

Cheng, T.; Liu, D.; Fernandez, J.; Griffin, J.H.; Zlokovic, B.V., 2002:
Neuroprotective and anti thrombotic effects of protein s in a murine model of stroke

Mion, G.; Tourtier, J-Pierre.; Petitjeans, F.; Dorandeu, Fédéric.; Lallement, G.; Rüttimann, M., 2003:
Neuroprotective and antiepileptic activities of ketamine in nerve agent poisoning

Bachurin, S.; Tkachenko, S.; Baskin, I.; Lermontova, N.; Mukhina, T.; Petrova, L.; Ustinov, A.; Proshin, A.; Grigoriev, V.; Lukoyanov, N.; Palyulin, V.; Zefirov, N., 2001:
Neuroprotective and cognition-enhancing properties of MK-801 flexible analogs. Structure-activity relationships

Blandini, F.; Armentero, M.; Fancellu, R.; Nappi, G., 2003:
Neuroprotective and functional effects of prolonged NMDA or mGluR5 blockade in a rodent model of Parkinsons disease

Pitossi, F.; D.P.olo, N.; Schoeneberg, A.; Depino, A.; Chertoff, C.; Ferrari, C.; Pfinzenmaier, K.; Podhajcer, O.; Eisel, U., 2003:
Neuroprotective and neurodegenerative effects of the chronic expression of TNF in the substantia nigra of adult mice

Brann, Darrell, W., 2001:
Neuroprotective and neurosecretory actions of estrogens

Kapural, M.; Drummond Webb, J.J.; Mee, R.B.; Starr, N.J.; Bokesch, P.M., 1999:
Neuroprotective anesthetic, and cardiovascular effects of the NMDA-antagonist CNS5161A

Cavazza, Claudio, 2002:
Neuroprotective composition for the prevention and/or treatment of nervous and behavioural alterations due to anxiety states or depression, comprising acetyl-L-carnitine and hypericin

Grimee, R.I.; Vanneste, J.; Segal, J.; Klitgaard, H., 2001:
Neuroprotective compounds in the MPTP model of Parkinsons disease lack protective effects against neurodegeneration induced by the neurotoxin 2-NH2-MPTP

Tsao, L.; Su, T.P., 2001:
Neuroprotective delta opioid DADLE blocks the Bax translocation and oligomerization induced by neurodegenerative psychostimulant methamphetamine

Garcia, R.A.G.; Hu, Z.Y.; Liu, L.S.; Noble, M.M.; Gonzalez, A.; Von Borstel, R.W.; Saydoff, J.A., 2002:
Neuroprotective doses of the oral uridine prodrug pn401 greatly exceed doses required to correct a pyrimidine deficiency

Dohi, K.; Satoh, K.; Ikeda, Y.; Ohtaki, H.; Shioda, S.; Aruga, T., 2003:
Neuroprotective effect from ischemia and direct free radical scavenging activity of Choto-san

Hong, K.W.an; Kim, K.Y.ung; Lee, J.H.un; Shin, H.K.oung; Kwak, Y.G.un; Kim, S.O.; Lim, H.; Yoo, S.E.n, 2002:
Neuroprotective effect of -N-cyano-N- -N-benzylguanidine , a benzopyran analog, against focal ischemic brain damage in rats

Chan, V.W.; Yip, H.K.; So, K.F.; Wu, W.T.; Ho, S.L., 2001:
Neuroprotective effect of 17-beta estradiol against 1-methyl-4-phenylpyridinium induced dopaminergic neuronal toxicity in vitro

Besson, V.; Croci, N.; Plotkine, M.; Marchand Verrecchia, C., 2002:
Neuroprotective effect of 3-aminobenzamide, a PARP inhibitor, in traumatic brain injury

Yu, S-Shan.; Zhao, J.; Zheng, W-Ping.; Zhao, Y., 2010:
Neuroprotective effect of 4-hydroxybenzyl alcohol against transient focal cerebral ischemia via anti-apoptosis in rats

RathinamArunaDevi; SumanLata; Bhadoria,B.K.; Ramteke,V.D.; SaurabhKumar; PalanisamySankar; DineshKumar; Tandan,S.K., 2010:
Neuroprotective effect of 5,7,3,4,5-pentahydroxy dihdroflavanol-3-O- - beta -d-glucopyranoside, a polyphenolic compound in focal cerebral ischemia in rat

Inoue Matsuhisa, E.; Sogo, S.; Mano, T.; Yano, S., 2000:
Neuroprotective effect of 5-HT2 receptor antagonist, MCI-9042, on glutamate-induced retinal ganglion cell death in culture

Kitahara, Y.; Takesue, K.; Miura, K.; Takeda, T.; Hirose, K.; Suzuki, K.; Kihara, H., 2003:
Neuroprotective effect of AT-1015, a novel 5-HT2A antagonist, in experimental diabetic neuropathy

El-Remessy, A.B.; Khalil, I.E.; Matragoon, S.; Abou-Mohamed, G.; Tsai, N-Jer.; Roon, P.; Caldwell, R.B.; Caldwell, R.W.; Green, K.; Liou, G.I., 2003:
Neuroprotective effect of (-)Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite

Srivastava,A.; Shivanandappa,T., 2010:
Neuroprotective effect of Decalepis hamiltonii roots against ethanol-induced oxidative stress

Kaneda, Y.; Teramoto, T.; Hatakeyama, S.; Ueno, M.; Niidome, T.; Komatsu, M.; Yamamoto, N.; Suzuki, Y.; IImura, Y.; Nishizawa, Y., 2001:
Neuroprotective effect of E2050, a novel neuronal calcium channel blocker, against brain injury after focal ischemia in rats

Quang, L.S.; Sadasivan, S.; Maher, T.J.; Shannon, M.W., 2003:
Neuroprotective effect of GHB, GBL, and 1,4-BD on rat focal cerebral ischemia by permanent middle cerebral artery occlusion

Hasegawa, H.; Nakajima, Y.; Liou, S.Y.h; Iwasawa, Y., 1999:
Neuroprotective effect of GV150526, an NMDA receptor glycine site antagonist, on acute subdural hematoma induced brain damage in the rat

Belayev, L.; Alonso, O.F.; Busto, R.; Liu, Y.; Ginsberg, M.D., 2000:
Neuroprotective effect of LY300164, a novel non-competitive AMPA antagonist, after traumatic brain injury in rats

Rhodes, P.G.; Xiao, F.; Cai, Z., 2000:
Neuroprotective effect of LY379268, a Group II metabotropic glutamate receptor agonist, on hypoxic-ischemic brain injury in a neonatal rat model

Huang, H.M.; Shen, J.C.; Hsueh, S.J.; Yu, J.Y.; Ou, H.C., 1999:
Neuroprotective effect of MK801 on the nitric oxide synthase following hypoxia-reoxygenation

Lu, X.C.M.; Liu, W.L.; Tang, Z.; Lin, Q.; Wozniak, K.; Estrada, J.; Wu, Y.; Slusher, B.S., 1999:
Neuroprotective effect of NAALADase inhibition in rat MCAO is partially mediated through TGF-beta

Kanthasamy, A.G.; Nguyen, B.O.; Truong, D.D., 1999:
Neuroprotective effect of NMDA/glycine site antagonists in an experimental model of cardiac arrest-induced movement disorders

Smialowska, M.; Wieronska, J.M.; Szewczyk, W.B., 2003:
Neuroprotective effect of NPY in rat hippocampus

Gonzalez, B.J.; Vaudry, D.; Pamantung, T.F.; Basille, M.; Fournier, A.; Vaudry, H., 2001:
Neuroprotective effect of PACAP against C2-ceramide-induced apoptosis of cerebellar granule cells

Reglodi, D.; Somogyvari Vigh, A.; Vigh, S.; Arimura, A., 1999:
Neuroprotective effect of PACAP38 in a rat transient focal ischemia model

Ohtaki, H.; Dohi, K.; Yin, L.; Nakamachi, T.; Takaki, A.; Nakajo, S.; Shioda, S., 2003:
Neuroprotective effect of PACAP38 through IL-6 after focal ischemia in mouse

Araneo, B.A.; Zivin, J.A., 2000:
Neuroprotective effect of PB007 on focal and multifocal ischemic injury of central nervous tissue in the rabbit

Kim, B.H.; Kim, J.; Park, J.H.; Won, R.; Sohn, N.W., 2001:
Neuroprotective effect of Rhei Rhizoma following transient global ischemia in gerbils

Ikeda, K.; Iwasaki, Y.; Kinoshita, M.; Ono, S.; Marubuchi, S., 1999:
Neuroprotective effect of T-588, a novel motor function enhancer, on wobbler murine motoneuron disease

Nakajima, A.; Yamada, K.; Tran, M.H.ng; Seto, A.; Saito, K.; Seishima, M.; Nabeshima, T., 2002:
Neuroprotective effect of TNF-alpha on methamphetamine-induced neurotoxicity in mice

de Almeida, L.P.; Zala, D.; Aebischer, P.; Déglon, N., 2001:
Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease

Takamatsu, H.; Tsukada, H.; Kataoka, Y.; Cui, Y.; Watanabe, Y.; Hosoya, T.; Suzuki, M.; Watanabe, Y., 2001:
Neuroprotective effect of a central type prostacyclin receptor ligand in a rat model of focal cerebral ischemia

Omata, N.; Murata, T.; Maruoka, N.; Wada, Y.; Yonekura, Y.; Fujibayashi, Y., 2003:
Neuroprotective effect of a free radical scavenger and an NMDA antagonist against hypoxia on gray and white matter as revealed by dynamic positron autoradiography

Ginsberg, M.D.; Becker, D.; Belayev, L.; Alonso, O.; Liu, Y.; Ley, J.; Fernandez, G.; Busto, R., 2001:
Neuroprotective effect of a novel azulenyl nitrone antioxidant after traumatic brain injury in rats

Faden, A.I.; Fox, G.B.; Zhang, T.; Mullins, P.; Di, X., 2000:
Neuroprotective effect of a novel cyclic dipeptide analog , of a thyrotropin-releasing hormone derivative, following controlled cortical impact in mice

Stasi, M.A.; Ursillo, A.; Taurelli, R.; Belluci, A.; Pacifici, L.; Carminati, P., 2000:
Neuroprotective effect of acetyl-l-carnitine on peripheral neuropathy induced by taxol and cisplatin

Wehrwein, E.; Thompson, S.; Linn, D.M.; Linn, C.L., 2002 :
Neuroprotective effect of acetylcholine on pig retinal ganglion cells is mediated through a nicotinic receptor

Nakatani, M.; Taki, C.; Goto, K.; Matsudaira, K.; Nishimura, S., 2003:
Neuroprotective effect of adenosine on calibrated optic nerve injury in rats

Jin, C.; Jung, K.J.; Lee, M.J.; Cho, E.Y.; Song, Y.S.; Lee, Y.S., 2003:
Neuroprotective effect of aloesin in a rat model of transient focal cerebral ischemia

Kaul, S.; Anantharam, V.; Kanthasamy, A., 2003:
Neuroprotective effect of alpha-synuclein involves attenuation of caspase-3 dependent proteolytic activation of PKCdelta in MPP+-induced apoptosis

Shin, J.; Sohn, C.; Park, E.; Kim, S.; Kim, G.; Jung, H.; Won, R.; Sohn, N., 2003:
Neuroprotective effect of an oriental medicinal formula on transient global ischemia of the aged rats

Kitagawa, K.; Matsumoto, M.; Hori, M.; Yanagihara, T., 2002:
Neuroprotective effect of apolipoprotein E against ischemia

Lagace, B.; Gelinas, S.; Chiasson, K.; Ramassamy, C.; Martinoli, M.G., 2001:
Neuroprotective effect of b-estradiol and Ginkgo biloba extracts on MPP+ and Paraquat induced cytotoxicity in PC12 cells

Zhang, S.; Ye, J.; Dong, G., 2010:
Neuroprotective effect of baicalein on hydrogen peroxide-mediated oxidative stress and mitochondrial dysfunction in PC12 cells

Tsuji, A.; Gu, Z.; Sawada, A.; Yamamoto, T.; Kitazawa, Y., 2000:
Neuroprotective effect of betaxolol in a rat experimental glaucoma model

Woldemussie, E.; Ruiz, G.; Wijono, M.; Wheeler, L.A., 2000:
Neuroprotective effect of brimonidine in chronic ocular hypertensive rats

Ahmed, F.; Hegazy, K.; Chaudhary, P.; Sharma, S.C., 1999:
Neuroprotective effect of brimonidine on adult rat retinal ganglion cells after increased intraocular pressure

Lin, A.M.Y.; Fan, S.F.; Luh, T.Y.; Ho, L.T., 1999:
Neuroprotective effect of carboxyfullerene on MPP+-induced neurodegeneration of nigrostriatal dopaminergic system in rat brain

Belokopytov, M.; Dubinsky, G.; Epstein, Y.; Belkin, M.; Rosner, M., 2003:
Neuroprotective effect of copolymer 1 vaccination in laser induced retinal damage

Otellin, V.A.; Korzhevskii, D.E.; Kostkin, V.B.; Balestrino, M.; Lensman, M.V.; Polenov, S.A., 2003:
Neuroprotective effect of creatine in brain ischemia

Lam, T.T.; Chiu, C.K.; Li, W.W.Y., 2000:
Neuroprotective effect of cyclosporine a in a rat model of chronic elevated intraocular pressure

Liou, G.I.; Matragoon, S.; E.R.messy, A.B.; Khalil, I.E.; Abou Mohamed, G.; Tsai, N.T.; Caldwell, R.W.; Caldwell, R.B., 2003:
Neuroprotective effect of d9 tetrahydrocannabinol in nmda induced apoptosis in rat retina

Stoltenburg Didinger, G.; Abdul Khaliq, H.; Schubert, S.; Troitzsch, D.; Boettcher, W.; Wehsack, A.; Hetzer, R.; Lange, P.E., 2000:
Neuroprotective effect of deep hypothermia in a piglet model of circulatory arrest with cardiopulmonary bypass

Mehta, S.H.; Dorrance, A.M.; Webb, R.C.inton, 2002:
Neuroprotective effect of deferoxamine in acute ischemic stroke in spontaneously hypertensive rats

Zhang, W.; Wang, T.G.; Qin, L.Y.; Gao, H.M.; Wilson, B.; Ali, S.F.; Zhang, W.Q.; Hong, J.; Liu, B., 2003:
Neuroprotective effect of dextromethorphan in the MPTP Parkinsons disease model role of NADPH oxidese

Lee, J.; Duan, W.; Herman, J.P.; Mattson, M.P., 2000:
Neuroprotective effect of dietary restriction involves a stress response and increased expression of neurotrophic factors

Coste, T.C.arles; Gerbi, A.; Cara, L.; Portugal, H.; Vague, P.; Pieroni, G.; Raccah, D., 2000:
Neuroprotective effect of docosahexaenoic acid in diabetic neuropathy

Torbey, M.T.; Martin, L.J.; Traystman, R.J.; Koehler, R.C., 2003:
Neuroprotective effect of dopamine receptor antagonist against striatal damage caused by asphyxic cardiac arrest in newborn piglets

Gelinas, S.; Valastro, B.; Chiasson, K.; Martinoli, M.G., 2002:
Neuroprotective effect of estradiol and phytoestrogens on mpp+ induced toxicity in neuronal pc12 cells

Zhang, L.; Willing, L.B.; Vannucci, S.J., 2000:
Neuroprotective effect of estrogen in diabetic stroke

Gelinas, S.; Graham, M.; Martinoli, M.G., 2000:
Neuroprotective effect of estrogen-like compounds on MPP+ and paraquat-induced cytotoxicity in PC12 cells

Heck, S.; Moosmann, B.; Behl, C., 1999:
Neuroprotective effect of estrogens and crosstalk with intracellular signal transduction cascades

Gerbi, A.; Maixent, J.M.; Barbey, O.; Jamme, I.; Pierlovisi, M.; Coste, T.; Pieroni, G.; Nouvelot, A.; Vague, P.; Raccah, D., 1999:
Neuroprotective effect of fish oil in diabetic neuropathy

Quang, L.S.; Sadasivan, S.; Maher, T.J.; Shannon, M.W., 2003:
Neuroprotective effect of gamma-hydroxybutyrate and its precursors, gamma-butyrolactone and 1,4-butanediol

Catalano, V.; Cascinu, S.; Labianca, R.; Giordani, P.; Mosconi, S.; Cordella, L.; Ubiali, E.; Baldelli, A.M.; Pessi, M.A.; Catalano, G., 2001:
Neuroprotective effect of glutathione on oxaliplatin -based chemotherapy in advanced colorectal cancer patients A randomized double-blind placebo-controlled trial

Chattopadhyay, M.; Mata, M.; Goins, W.; Wolfe, D.; Huang, S.; Glorioso, J.C.; Fink, D.J., 2002:
Neuroprotective effect of hsv mediated neurotrophin gene transfer in cisplatin neuropathy

Liu, Y.; Belayev, L.; Zhao, W.; Busto, R.; Ginsberg, M.D., 2000:
Neuroprotective effect of human albumin therapy in focal cerebral ischemia dose-response and therapeutic window

Varathan, S.; Shibuta, S.; Shimizu, T.; Mashimo, T., 2001:
Neuroprotective effect of hypothermia at defined intra-ischemic time-course in cultured cortical neurons

Kawano, T.; Fukunaga, K.; Ushio, Y.; Miyamoto, E., 2000:
Neuroprotective effect of insulin like growth factor-I through protein kinase B activation in transient forebrain ischemia

Bensadoun, J.C.; D.A.meida, L.P.reira; Dreano, M.; Aebischer, P.; Deglon, N., 2001:
Neuroprotective effect of interleukin-6 and IL6/IL6R chimera in the quinolinic acid rat model of Huntingtons disease

Yi, Y.H.; Guo, W.C.; Liao, W.P.; Sun, W.W., 2003:
Neuroprotective effect of lamotrigine on hypoxic-ischemic encephalopathy in neonatal rats

Inomata, Y.; Hirata, A.; Koga, T.; Shinohara, T.; Shingh, D.P.; Kimura, A.; Tanihara, H., 2003:
Neuroprotective effect of lens epithelium derived growth factor on n methyl d aspartate induced cell death in rat retina

Pitkanen, A.; Goemare, J.; Matagne, A.; Klitgaard, H., 2004:
Neuroprotective effect of levetiracetam on status epilepticus-induced neuronal damage

Cervantes, M.; Letechipia, G.; Burgos, I.G., 2000:
Neuroprotective effect of melatonin upon the brain damage induced by acute global cerebral ischemia, in cats

Ruiz, G.; Yoles, E.; Schwartz, M.; Wheeler, L.A.; Woldemussie, E., 2001:
Neuroprotective effect of memantine in different ganglion cell injury models

Nathan, H.J.; Munson, J.; Wells, G.A.; Harrison, M., 1999:
Neuroprotective effect of mild hypothermia in patients undergoing coronary artery surgery

Mooney, S.M.; Miller, M.W., 2003:
Neuroprotective effect of nerve growth factor is age-dependent

Kihara, T.; Shimohama, S.; Honda, K.; Shibasaki, H.; Akaike, A., 2000:
Neuroprotective effect of nicotinic agonists via PI3 kinase cascade against glutamate cytotoxicity enhanced by beta amyloid

Heinel, L.A.; Mays, P.K.; Tzodikov, N.R., 2002:
Neuroprotective effect of oral administration of CPG-603 in rats subjected to middle cerebral artery occlusion

Binienda, Z.K.; Scallet, A.C., 1999:
Neuroprotective effect of perinatal hypoxia against 3-nitropropionic acid neurotoxicity

Copeland, R.L.; Leggett, Y.A., 2003:
Neuroprotective effect of propranolol on salsolinol - induced cytotoxicity in human SH - SY5Y neuroblastoma cells

Almeida, S.; Oliveira, C.R.; Rego, A.C., 2003:
Neuroprotective effect of protein phosphatase 2B inhibitor and NGF in apoptosis induced by 3 - nitropropionic acid in cortical cultures

Yonemura, N.; Hirata, A.; Inomata, Y.; Koga, T.; Honjo, M.; Tanihara, H., 2003:
Neuroprotective effect of rho associated protein kinase inhibitor, y 27632, in the eye

Suganthy,N.; Pandian,S.K.; Devi,K.P., 2010:
Neuroprotective effect of seaweeds inhabiting South Indian coastal area cholinesterase inhibitory effect of Hypnea valentiae and Ulva reticulata

Goyagi, T.; Goto, S.; Bhardwaj, A.; Dawson, V.L.; Hurn, P.D.; Kirsch, J.R., 2001:
Neuroprotective effect of sigma1-receptor ligand 4-phenyl-1- piperidine is linked to reduced neuronal nitric oxide production

Kharlamov, A.; Jones, S.C.; Kim, D.K., 2001:
Neuroprotective effect of suramin in a model of focal ischemia in rats

D.S.moni, M.; Echart, C.; Marzorati, P.; Storini, C.; Rossi, E.; Piovesan, P.; Ghirardi, O., 2003:
Neuroprotective effect of the 2 - aminotetraline derivative ST1942 on ischemia / reperfusion brain injury

Guerrero, A.; Cansino, A.L.; Gonzalez Correa, J.A.; Arrebola, M.M.; Munoz Marin, J.; Ruiz Villafranca, D.; Sanchez, D.L.C.esta, F.; D.L.C.uz, J.P., 2003:
Neuroprotective effect of the association aspirin-vitamin E in experimental diabetes mellitus

Cutillas, B.; Ambrosio, S.; Unzeta, M., 2002:
Neuroprotective effect of the monoamine oxidase inhibitor PF 9601N -2- methylamine on rat nigral neurons after 6-hydroxydopamine-striatal lesion

Kupina, N.C.; Detloff, M.R.; Dutta, S.; Hall, E.D., 2001:
Neuroprotective effect of the neuroimmunophilin V-10,367 following 24-h delayed administration in a mouse model of traumatic brain injury

Takahashi, M.; Haberg, A.; Hjelstuen, M.; Okada, M.; Yamaguchi, T.; Haraldseth, O., 1999:
Neuroprotective effect of the novel AMPA receptor antagonist YM872 assessed with in-vivo MR imaging of rat MCA occlusion

Pardue, M.T.; Ball, S.L.; Yin, H.; Phillips, M.J.; Peachey, N.S.; Hanzlicek, B.; Sippy, B.; Chow, A.Y., 2003:
Neuroprotective effect of the subretinal artificial silicon retina

Banaskiewicz, R.; Vorwerk, C.K.; Ruiz, G.; Wheeler, L.A.; Woldemussie, E., 2003:
Neuroprotective effect of topical administration of alphagan p in rats with laser induced chronic ocular hypertension

Urena, I.M.; Guerrero, A.; Arrebola, M.M.; Gonzalez Correa, J.A.; Sanchez, D.L.C.esta, F.; D.L.C.uz, J.P., 2002:
Neuroprotective effect of triflusal in rat brain slices subjected to oxygen-glucose deprivation and reoxygenation Role of its antioxidant effect

Savarese, A.; Pace, A.; Pacetti, U.; Maresca, V.; Del Monte, G.; Picardo, M.; Jandolo, B.; Cognetti, F., 2001:
Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin-based chemotherapy

Kim, E.H.; Kim, H.; Rhyu, I.J.; Uhm, C.S.; Chin, J.H.; Kim, Y.R.; Eun, B.L., 2000:
Neuroprotective effects by magnesium sulfate treatment on hypoxic-ischemic brain injury in the newborn rat

Li, D.Z.ou; Marchand Verrecchia, C.; Palmier, B.; Croci, N.; Chabrier, P.E.ienne; Plotkine, M.; Margaill, I., 2003:
Neuroprotective effects of -N- carbonyl-1-piperazinylphenyl-2-thiophenecarboximid-amide

Nagai, K.; Jian, M.H.; Nishizaki, T.; Hada, J.; Yajima, Y.; Tozaki, H.; Kanno, T.; Kawajiri, S., 2001:
Neuroprotective effects of -epigallocatechin gallate against neural toxicity of nitric oxide in the hippocampus

Jang, S.; Jeong, H-Seong.; Park, J-Seong.; Kim, Y-Seon.; Jin, C-Yan.; Seol, M.Bok.; Kim, B-Chae.; Lee, M-Cheol., 2010:
Neuroprotective effects of (-)-epigallocatechin-3-gallate against quinolinic acid-induced excitotoxicity via PI3K pathway and NO inhibition

Canudas, A.M.; Pubill, D.; Sureda, F.X.; Verdaguer, E.; Camps, P.; Muñoz-Torrero, D.; Jiménez, Aés.; Camins, A.; Pallàs, Mè., 2003:
Neuroprotective effects of (+/-)-huprine Y on in vitro and in vivo models of excitoxicity damage

Schmidt, N.; Ferger, B., 2001:
Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease

Ducrocq, S.; Plotkine, M.; Ben Ari, Y.; Charriaut Marlangue, C., 2000:
Neuroprotective effects of 3-amino-benzamide, a PARP inhibitor, on focal cerebral ischemia in rat pups

Szabo, L.; Behl, B.; Garcia Ladona, F.J.; Hofmann, H.P.; Hornberger, W.; Mack, H.; Steiner, G.; Teschendorf, H.J.; Unger, L., 2002:
Neuroprotective effects of 5 ht1a receptor agonists

Popoli, P.; Tebano, M.T.; Frank, C.; Pintor, A.; Domenici, M.R.; Potenza, R.L.; Martire, A.; Pepponi, R.; Pezzola, A.; Reggio, R.; D.B.rardinis, M.A.; Minghetti, L., 2003:
Neuroprotective effects of A2A receptor antagonists on basal ganglia neurodegenerative diseases

Presgraves, S.P.; Vishnivetskaya, T.A.; Joyce, J.N., 2001:
Neuroprotective effects of D3 agonists against MPP+ and L-dopa/DA-induced neurotoxicity in SH-SY5Y cells

D.C.istobal, J.; Cardenas, A.; Fernandez Tome, P.; Leza, J.C.; Lizasoain, I.; Lorenzo, P.; Moro, M.A., 1999:
Neuroprotective effects of DETA-NONOate on hydrogen peroxide-induced neurotoxicity in cortical neurones

Ohkuma, K.; Nakajima, H.; Kakui, N.; Ishikawa, M.; Hasegawa, T.; Hiranuma, T.; Ichimaru, Y.; Hoshiko, S., 2000:
Neuroprotective effects of DR2313, a newly synthesized poly polymerase inhibitor, in rat focal cerebral ischemia

Heyburn, J.W.; Vinegra, M.A.; Gonzales, C.; Miller, T.L.; Bramlett, D.R.; Xiao, Y.; Moyer, J.A.; Zaleska, M.M., 1999:
Neuroprotective effects of EAA-090, a novel competitive NMDA receptor antagonist in focal cerebral ischemia models

Bell, C.; Trillo Pazos, G.; Everall, I., 2000:
Neuroprotective effects of FGF1 against gp120-mediated toxicity in primary human neurones

Takamatsu, H.; Tsukada, H.; Umemura, K., 2000:
Neuroprotective effects of FK506 against ischemic neuronal cell death

Takamatsu, H.; Noda, A.; Tsukada, H.; Kakiuchi, T.; Nishimura, S.; Umemura, K., 2000:
Neuroprotective effects of FK506 in a monkey model of stroke A PET study

Villegas, S.N.buel; Poletta, F.A.rian; Carri, N.G.briel, 2001:
Neuroprotective effects of GDNF and NT-3 on clonal glial cell line

Ying Wang, J.; Peruzzi, F.; Lassak, A.; Del Valle, L.; Radhakrishnan, S.; Rappaport, J.; Khalili, K.; Amini, S.; Reiss, K., 2002:
Neuroprotective effects of IGF-I against TNFalpha-induced neuronal damage in HIV-associated dementia

Binienda, Z.K., 2003:
Neuroprotective effects of L-carnitine in induced mitochondrial dysfunction

Nagayama, T.; Miyata, A.; Hirano, H.; Obara, S.; Niiro, M.; Kuratsu, J., 2003:
Neuroprotective effects of Maxadilan, a pituitary adenylate cyclase activating polypeptide - specific receptor agonist, in global cerebral ischemia and in hypoxic neuronal cultures

Gertz, K.; Harms, C.; Jagtap, P.; Salzman, A.; Dirnagl, U.; Szabo, C.; Endres, M., 2000:
Neuroprotective effects of PJ34, a novel, potent inhibitor of poly polymerase

Lapanantasin, S.; Chindewa, R.; Chaovipoch, P.; Chongthammakun, S., 2004:
Neuroprotective effects of Pueraria mirifica on ischemic-induced neuronal death

Han, Y.; Quirion, R., 2003:
Neuroprotective effects of Rhodiola rosea extract on beta - amyloid - induced neurotoxicity

Presgraves, S.P.; Ahmed, T.; Millan, M.J.; Joyce, J.N., 2003:
Neuroprotective effects of S32504 and pramipexole in terminally differentiated SH - SY5Y cells are mediated by the D3 receptor

Popoli, P.; Tebano, M.T.; Pintor, A.; Domenici, M.R.; Frank, C.; Albedi, F.M.lchiodi; Falchi, M.; Pezzola, A.; Reggio, R., 2001:
Neuroprotective effects of SCH 58261, an adenosine A2A receptor antagonist, in a rat model of Huntingtons disease

Ferzaz, B.; Robert, J.P.; Bourliaud, G.; Brault, E.; Poughon, G.; Liere, P.; Schumacher, M.; Nowicki, J.P.; Fournier, J.; Sevrin, M.; Marabout, B.; George, P.; Soubrie, P.; Scatton, B., 2001:
Neuroprotective effects of SSR180575 a peripheral benzodiazepine receptor ligand

Zhang, Y.; Busto, R.J.; Ginsberg, M.D.; Becker, D.A.; Ley, J.J.; Raval, A.P.; Belayev, L.; Perez Pinzon, M.A., 2003:
Neuroprotective effects of STAZN, a novel azulenyl nitrone antioxidant, against oxygen - glucose deprivation in the rat organotypic hippocampal slice

Ikeda, Y.; Tamura, S.; Shimonaga, T.; Tsukada, H.; Umemura, K., 2004:
Neuroprotective effects of SUN N8075 in a monkey model of stroke

Skvortsova, V.I.; Gusev, E.I.; Alexeev, A.A.; Myasoedov, N.F.; Raevsky, K.S., 2001:
Neuroprotective effects of Semax in acute ischaemic stroke

Keene, C.D.; Rodrigues, C.M.P.; Eich, T.; Linehan Stieers, C.; Abt, A.; Kren, B.T.; Steer, C.J.; Low, W.C., 2001:
Neuroprotective effects of TUDCA, a hydrophilic bile acid, in experimental Huntingtons disease

Suzuki, M.; Sasamata, M.; Miyata, K., 2003:
Neuroprotective effects of YM872 combined with thrombolytic therapy in a rat embolic stroke model

Joyce, J.N.; Woolsey, C.; Ryoo, H.; Presgraves, S., 2001:
Neuroprotective effects of a clinically relevant dose of pramipexole in MPTP-treated mice

Miyazaki, H.; Tanaka, S.; Fujii, Y.; Shimizu, K.; Nagashima, K.; Kamibayashi, M.; Uehara, T.; Okuma, Y.; Nomura, Y., 1999:
Neuroprotective effects of a dihydropyridine derivative, 1,4-dihydro-2,6-dimethyl-4- -3,5-pyridinedicarboxylic acid methyl 6- hexyl ester , on rat ischemic brain injury

Yoshii, N.; Ohgami, T.; Yamaguchi, H.; Ando, R.; Saido, T.C.; Saito, K.I., 1999:
Neuroprotective effects of a novel orally active reversible calpain inhibitor BDA-410

Iwashita, A.; Yamazaki, S.; Mihara, K.; Hattori, K.; Yamamoto, H.; Ishida, J.; Matsuoka, N.; Mutoh, S., 2004:
Neuroprotective effects of a novel poly polymerase-1 inhibitor, 2- -l-piperazinyl propyl-4

Kawamura, Yuuki; Maruyama, Kei; Saito, Yumiko; Usuki, Fusako, 2004:
Neuroprotective effects of alpha - tocopherol transfer protein on oxidative stress

Marinescu, D.; Tiu, C.; Bajenaru, O., 2000:
Neuroprotective effects of alpha-lipoic acid in acute focal cerebral ischemia in humans

Fox, C.M.; Wilcher, J., 1999:
Neuroprotective effects of antioxidants in the rat model of Parkinsons disease

Westman, Jan, 2003:
Neuroprotective effects of antioxidants on heat shock protein and the blood-brain barrier in hyperthermic brain injury

Dok-Go, H.; Lee, K.Heun.; Kim, H.Ja.; Lee, E.Ha.; Lee, J.; Song, Y.Seon.; Lee, Y-Ha.; Jin, C.; Lee, Y.Sup.; Cho, J., 2003:
Neuroprotective effects of antioxidative flavonoids, quercetin, (+)-dihydroquercetin and quercetin 3-methyl ether, isolated from Opuntia ficus-indica var. saboten

Kagiyama, T.; Glushakov, A.V.; Sumners, C.; Roose, B.; Dennis, D.M.; Phillips, M.I.; Ozcan, M.; Seubert, C.N.; Martynyuk, A.E., 2003:
Neuroprotective effects of aromatic amino acids and their derivatives

Lee, K.Y.; Borowski, T.; Delacalle, S., 2003:
Neuroprotective effects of bcl-2 on cholinergic neurons in the basal forebrain

Chou, J.; Mark, A.; Harvey, B.K.; Chen, S.; Wang, Y.; Hoffer, B.J., 2003:
Neuroprotective effects of bone morphogenetic protein 7 in a rat model of Parkinsons disease

Kido, N.; Tanihara, H.; Honjo, M.; Inatani, M.; Okazaki, K.; Honda, Y., 1999:
Neuroprotective effects of brain-derived neurotrophic factor in eyes with glutamate receptor-mediated neuronal death

Lafuente, M.P.; Villegas Perez, M.P.; Aguilera, M.E.; Mayor Torroglosa, S.; Miralles, D.I.perial, J.; Vidal Sanz, M., 2001:
Neuroprotective effects of brimonidine on transient ischemia-induced retinal ganglion cell death

Ichikawa, M.; Goto, W.; Ishida, R.; Hara, H., 2002:
Neuroprotective effects of bunazosin hydrochloride, an alpha 1 adrenoreceptor antagonist, in rat primary retinal culture

Sander, J.; Odin, P.; Milde, S.; Dengler, R., 1999:
Neuroprotective effects of cabergoline in the rat 6-OHDA Parkinson model

Ross, G.Webster, 2001:
Neuroprotective effects of caffeine and nicotine

Pallas, M.; Knop, C.; Behrens Baumann, W.; Vorwerk, C.K., 2003:
Neuroprotective effects of calpain inhibitor mdl 28170 in a model of intravitreal excitotoxicity

Fujimaki, K.; Chuang, D.M., 2003:
Neuroprotective effects of corticotropin - releasing factor against glutamate excitotoxicity in rat cerebral cortical neurons a role of protein kinase C and Bcl - 2

Leventhal, L.; Sortwell, C.E.; Palfi, S.; Kladis, T.; Collier, T.J.; Kordower, J.H., 1999:
Neuroprotective effects of cyclosporin A from the mitochondrial toxin 3-nitropropionic acid

Hanbury, R.; Leventhal, L.; Palfi, S.; Sortwell, C.E.; Collier, T.J.; Kordower, J.H., 2000:
Neuroprotective effects of cyclosporin A from the mitochondrial toxin 3-nitropropionic acid in vivo

Ferrante, R.J.; Dedeoglu, A.; Mahoney, S.; Beal, M.F.; Hersch, S.M., 2001:
Neuroprotective effects of cystamine in Huntingtons disease transgene R6/2 mice

Chiang, Y.H.; Wang, Y.; Chang, C.F.; Morales, M.; Su, T.P.; Thiemermann, C., 2002:
Neuroprotective effects of diadenosine teraphosphate against cerebral inschemia in rats

Shimizu, K.; Rajapakse, N.; Busija, D.W., 2001:
Neuroprotective effects of diazoxide, a selective opener of mitochondrial ATP sensitive potassium channels , against transient focal cerebral ischemia in rats

Winkler, T.; Sharma, H.S.; Stalberg, E.; Westman, J., 2001:
Neuroprotective effects of dynorphin antiserum in spinal cord injury

Wise, P.M.; Dubal, D.B., 1999:
Neuroprotective effects of estradiol in aging female rats

Sawada, H.; Shimohama, S., 2000:
Neuroprotective effects of estradiol in mesencephalic dopaminergic neurons

Bi, R.; Arst, D.; Baudry, M., 1999:
Neuroprotective effects of estrogen against excitotoxicity in cultured hippocampal slices

O'connor, L.T.; Daoud, P.; Deecher, D.C., 2002:
Neuroprotective effects of estrogens to glutamate toxicity in hippocampal cell line ht22 is mediated through the estrogen receptor

Chan, V.W.; Yip, H.K.; So, K.F.; Wu, W.T., 2000:
Neuroprotective effects of extracts from American gingseng, ginkgo biloba and St Johns Wort on striatal dopaminergic neurons against 1-methyl-4-phenyl-1,2,4,6-tetrahydropyridine-induced toxicity

Yu, M.S.; Yuen, W.H.; So, K.F.; Chang, R.C.C., 2004:
Neuroprotective effects of extracts from anti-aging chinese medicine Lycium barbarum

Toshima, Y.; Satoh, S.I.hi; Asano, T., 1999:
Neuroprotective effects of fasudil on ischemic brain damage in a new model of cerebral microthrombosis in rats

Ebisu, T.; Mori, Y.; Katsuta, K.; Fujikawa, A.; Matsuoka, N.; Umeda, M.; Naruse, S.; Tanaka, C., 2002:
Neuroprotective effects of fk506 on diffusion/perfusion mismatch in transient focal ischemia

Quang, L.S.; Sadasivan, S.; Maher, T.J., 2003:
Neuroprotective effects of gamma-hydroxybutyrate and its precursors 1,4-butanediol and gamma-butyrolactone in MCAo cerebral ischemia

Bang, O.Y.; Kim, D.H.; Kim, H.; Hong, H.S.; Joo, I.; Mook Jung, I.; Huh, K., 2001:
Neuroprotective effects of genistein against beta-amyloid-induced neuronal cell death

Zhuang, H.; Pin, S.; Christen, Y.; Dore, S., 2002:
Neuroprotective effects of ginkgo biloba is mediated by heme oxygenase

Liao, B.S.; Newmark, H.; Zhou, R., 2001:
Neuroprotective effects of ginseng total saponin, ginsenosides Rb1 and Rg1 on spinal cord neurons in vitro

Iannotti, C.; Zhang, Y.P.; Han, Y.; Burke, D.A.; Shields, C.B.; Xu, X.M., 2002:
Neuroprotective effects of glial cell line derived neurotrophic factor following moderate spinal cord contusion injury

Jones, K.J.; Brown, T.J.; Damaser, M., 2001:
Neuroprotective effects of gonadal steroids on regenerating peripheral motoneurons

Emond, M.P.scale; Pylarinos, A.; Lionel, C., 2002:
Neuroprotective effects of group I metabotropic glutamate antagonist on kainic acid-induced seizures in the mature rats

Sullivan, A.M.; Hurley, F.M.; Costello, D.J., 2001:
Neuroprotective effects of growth/differentiation factor-5 in rat models of Parkinsons disease

Wu, Y-Qian.; Limburg, D.C.; Wilkinson, D.E.; Jackson, P.; Steiner, J.P.; Hamilton, G.S.; Belyakov, S.A., 2003:
Neuroprotective effects of inhibitors of dipeptidyl peptidase-iV in vitro and in vivo

Kido, N.; Tanihara, H.; Honjo, M.; Inatani, M.; Yoneda, S.; Hara, H.; Miyawaki, N.; Honda, Y., 2000:
Neuroprotective effects of interleukin-1beta and interleukin-1 receptor antagonist in eyes with NMDA-induced neuronal death

Sunwoo, L.W.; Hayamizu, T.; Chan, P.T.; Guglielmo, M.A.; Doberstein, C.E.; Johanson, C.E., 1999:
Neuroprotective effects of intraventricular infusion of FGF-2 in an experimental rat model of forebrain ischemia

Bhardwaj, A.; Toung, T.K.; Traystman, R.J.; Koehler, R.C.; Hurn, P.D.; Kirsch, J.R., 2001:
Neuroprotective effects of kappa opioid receptor agonist in transient focal ischemia

Mora, A.; Sabio, G.; Centeno, F., 2003:
Neuroprotective effects of lithium Pointing out protein phosphatases as drug targets?

Movsesyan, V.A.; O'leary, D.M.; Fan, L.; Bao, W.; Mullins, P.G.; Knoblach, S.M.; Vicini, S.; Faden, A.I., 2000:
Neuroprotective effects of mGluR5 antagonists MPEP and SIB-1893 appears to be mediated through NMDA receptor antagonist action

Wang, C.; Yang, T.; Ren, J.; Shuaib, A., 2002:
Neuroprotective effects of mc 1 in a focal embolic model of cerebral ischemia in rats

Skottner, A.; Sharma, H.S.; Lundstedt, T.; Flardh, M.; Westman, J.; Post, C., 2003:
Neuroprotective effects of melanocortins in spinal cord injury

Guevara, B.H.; Campos, M.; Cespedes, G.; Cubeddu, L.X., 2001:
Neuroprotective effects of melatonin and methylisothiourea 0N cholinergic damage induced by kainic acid in the rat striatum

Takami, T.; Oudega, M.; Marcillo, A.E.; Bethea, J.R.; Bunge, M.B., 2000:
Neuroprotective effects of methylprednisolone and human IL-10 on the contused adult Fischer rat thoracic spinal cord

Hiroi, T.; Wei, H.; Kanai, H.; Leeds, P.; Chuang, D.M., 2001:
Neuroprotective effects of mood-stabilizing drugs in rat PC12 pheochromocytoma cells

Braidy, N.; Grant, R.; Adams, S.; Guillemin, G.J., 2010:
Neuroprotective effects of naturally occurring polyphenols on quinolinic acid-induced excitotoxicity in human neurons

Boo, Y.; Baek, S.; Lee, M.; Kang, T.; Rho, S.; Kong, M.; Ha, N.; Yu, Y.; Kim, H., 2003:
Neuroprotective effects of neutrio on cerebral ischemia in vivo and in vitro

Ryan, R.E.; Drago, J.; Ross, S.A.; Loiacono, R.E., 2001:
Neuroprotective effects of nicotine in Parkinsonian neurodegeneration-studies in the rat and nicotinic subunit alpha4 knockout mouse

Tariq, M.; Elfaki, I.; A.M.utaery, K.; A.D.eb, S., 2004:
Neuroprotective effects of nicotine in animal model of Huntington39;s disease

Murray, T.K.; Swettenham, J.B.; Hicks, C.A.; Winny, C.; O'neill, M.J., 2000:
Neuroprotective effects of nicotine in two experimental models of Parkinsons disease in the rat

Asanuma, M.; Miyazaki, I.; Ogawa, N., 2004:
Neuroprotective effects of nonsteroidal anti-inflammatory drugs on neurodegenerative diseases

Weinstock, M.; Kirschbaum-Slager, N.; Lazarovici, P.; Bejar, C.; Youdim, M.B.; Shoham, S., 2001:
Neuroprotective effects of novel cholinesterase inhibitors derived from rasagiline as potential anti-Alzheimer drugs

Vinik, A.I.; Pittenger, G.L.; Burcus, N.I.; Anderson, S.A.; Stansberry, K.B.; Mcnear, E.; Barlow, P.M., 2003:
Neuroprotective effects of novel neurotherapeutic topiramate in diabetic patients

Govindaswami, M.; Bishop, P.D.; Kindy, M.S.; Oeltgen, P.R., 2003:
Neuroprotective effects of opioid-like hibernation factors in cerebral ischemia

O'neill, M.J.; Murray, T.K.; Swettenham, J.B.; Hicks, C.A.; Ward, M.A., 1999:
Neuroprotective effects of pergolide in animal models of global cerebral ischaemia and Parkinsons disease

Nakamizo, T.; Shimohama, S.; Kawamata, J.; Kanki, R.; Sawada, H.; Kihara, T.; Yamashita, H.; Yoshida, K.; Kawai, Y.; Shibasaki, H.; Akaike, A., 2002:
Neuroprotective effects of phosphodiesterase inhibitors on cultured spinal motor neurons

Jiang, H.; Chen, J.; Zhang, L.; Zhang, C.; Hunter, T.; Chopp, M.; Levine, R.A., 2003:
Neuroprotective effects of pituitary adenylate cyclase activating polypeptide in a rat model of transient focal cerebral ischemia

Simpkins, J.W.; Gordon, K.; Green, P.S., 1999:
Neuroprotective effects of polycyclic phenolic compounds

Caggiano, N.; Wands, J.R.; D.L.M.nte, S.M., 2003:
Neuroprotective effects of polyglutamate compounds

Ho, Y-Shan.; Yu, M-Shan.; Yang, X-Fei.; So, K-Fai.; Yuen, W-Hung.; Chang, R.Chuen-Chung., 2010:
Neuroprotective effects of polysaccharides from wolfberry, the fruits of Lycium barbarum, against homocysteine-induced toxicity in rat cortical neurons

Kitamura, Y.; Kakimura, J.I.hi; Taniguchi, T., 2002:
Neuroprotective effects of pramipexole, a novel antiparkinsonian drug

Li, X.M.; Bai, O.; Qing, H.; Bowen, R.; Keegan, D., 2001:
Neuroprotective effects of quetiapine and other atypical antipsychotics

Li, C.; Yan, Z.; Yang, J.; Chen, H.; Li, H.; Jiang, Y.; Zhang, Z., 2010:
Neuroprotective effects of resveratrol on ischemic injury mediated by modulating the release of neurotransmitter and neuromodulator in rats

Lips, J.; Kalkman, C.J.; D.H.an, P.; Jacobs, M.J.H.M., 1999:
Neuroprotective effects of riluzole in a rabbit model of experimental spinal cord ischemia

Wahl, F.; Stutzmann, J.M., 1999:
Neuroprotective effects of riluzole in neurotrauma models: a review

Kawano, T.; Fukunaga, K.; Ushio, Y.; Miyamoto, E., 2001:
Neuroprotective effects of sodium orthovanadate on delayed neuronal death following transient forebrain ischemia through Akt activation

George, S.J.; Dhond, A.J.; Alderson, S.M.; Ezekowitz, M.D., 2002:
Neuroprotective effects of statins may not be related to total and low-density lipoprotein cholesterol lowering

Labrande, C.; Velly, L.; Canolle, B.; Guillet, B.; Masmejean, F.; Lortet, S.; Nieoullon, A.; Pisano, P., 2003:
Neuroprotective effects of tacrolimus in ischemic cortical cell cultures insights on the role of glutamate and FKBP12

Sadasivan, S.; Kalaria, H.; Quang, L.; Maher, T.J., 2004:
Neuroprotective effects of the GHB precursors gamma-butyrolactone and 1,4-butanediol in rats subjected to transient focal cerebral ischemia

Wallis, R.A.n; Panizzon, K.L.; Niquet, J.; Mazarati, L.; Baldwin, R.; Wasterlain, C.G., 2000:
Neuroprotective effects of the anticonvulsant, fluoro-felbamate

Pedersen, V.; Schmidt, W.J., 2000:
Neuroprotective effects of the dopamine agonist cabergoline in 6-OHDA lesioned rats

Chun, H.S.ok; Kim, J.M.ung; Choi, E.H.e; Kim, W.K.; Chang, N., 2003:
Neuroprotective effects of the garlic compound, S-allylcystein on the in vitro and in vivo ischemic damage

Popoli, P.; Pintor, A.; Tebano, M.T.; Frank, C.; Pepponi, R.; Domenici, M.R.; Martire, A.; Minghetti, L., 2003:
Neuroprotective effects of the mGlu5 receptor antagonist MPEP in a rat model of Huntingtons disease

Mathews, K.S.; Mclaughlin, D.P.; O'neill, M.J.; Stamford, J.A., 2000:
Neuroprotective effects of the neuronal calcium channel blocker LY 393615 against cerebral hypoxic-hypoglycaemic insult in vitro

Joyce, J.N.; Presgraves, S.; Renish, L.; Borwege, S.; Osredkar, T.; Hagner, D.; Replogle, M.; Pazsoldan, M.; Millan, M.J., 2003:
Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine A comparison to ropinirole

Miller, J.A.; Bialobok, P.; Gendron, P.; Malnowske, J.; Mccarthy, D.; Case, K.; Eisman, M.; Pierson, N.E.; Bostwick, J.R., 1999:
Neuroprotective effects of the selective neuronal-type calcium channel blocker, AR-R18565

Cavazos, J.E.; Kanske, J.; Perez, J.; Garcia, M., 2002:
Neuroprotective effects of topiramate in the kainic acid model of status epilepticus

Jeong, M.; Hashimoto, R.; Senatorov, V.; Fujimaki, K.; Chuang, D.M., 2002:
Neuroprotective effects of valproate in rat cerebral cortical neurons

Bond, A.; Hicks, C.A.; Ward, M.A.; Clark, B.P.; Monn, J.A.; Kingston, A.E.; Lodge, D.; O'neill, M.J., 2000:
Neuroprotective effects with novel mGluR1 , mGluR5 antagonists and mGluR2/3 agonists in vivo

Williams, A.J.; Dave, J.R.; Phillips, J.B.; Lin, Y.; Mccabe, R.T.ler; Tortella, F.C., 2000:
Neuroprotective efficacy and therapeutic window of the high-affinity N-methyl-D-aspartate antagonist conantokin-G In vitro and in vivo studies

Imai, H.; Graham, D.; Masayasu, H.; Macrae, I.M., 2000:
Neuroprotective efficacy of an intravenous formulation of ebselen in a rodent model of focal ischaemia

Wallis, R.A.n; Panizzon, K.L., 2003:
Neuroprotective efficacy of calcineurin in-hibitors against depolarization injury to CA1 pyramidal neurons in rat hippocampal slices

Wallis, R.A.n; Panizzon, K.L., 2002 :
Neuroprotective efficacy of caspase-9 inhibitors against depolarization injury to CA1 pyramidal neurons in rat hippocampal slices

Barks, J.D.E.; Duong, H.K.; Liu, X.H.ng, 1999:
Neuroprotective efficacy of recombinant platelet-activating factor acetylhydrolase in neonatal cerebral hypoxia-ischemia

Wallis, R.A.n; Panizzon, K.L.; Sofia, R.D.ane, 2001:
Neuroprotective efficacy of taurolidine against depolarization injury to CA1 pyramidal neurons in rat hippocampal slices

Littleton Kearney, M.T.; Klaus, J.; Hurn, P.D.; Sieber, F.E.; Alkayed, N.J., 2001:
Neuroprotective epoxyeicosatrienoic acids also reduce platelet reactivity ex vivo

Maruyama, W.; Yi, H.; Takahashi, T.; Shimazu, S.; Ohde, H.; Yoneda, F.; Iwasa, K.; Naoi, M., 2004:
Neuroprotective function of R- -1- -2-propylaminopentane, , against apoptosis induced by N-methyl salsolinol, an endogenous dopaminergic neurotoxin, in human dopaminergic neuroblastoma SH-SY5Y cells

Xu, J.; Yuan, M.; Yankner, B., 2001:
Neuroprotective function of a-synuclein and increased neuronal vulnerability from Parkinsons disease mutations

Conn, K.; Doherty, S.; Eisenhauer, P.; Fine, R.; Wells, J.; Ullman, M.D., 2003:
Neuroprotective ganglioside derivatives

Tenenbaum, L.; Chtarto, A.; Lehtonen, E.; Blum, D.; Baekelandt, V.; Velu, T.; Brotchi, J.; Levivier, M., 2002:
Neuroprotective gene therapy for Parkinson's disease

Mckeage, M.J.; Haddad, G.G.; Ding, L.; Galettis, P.; Screnci, D.; Baguley, B.C., 1999:
Neuroprotective interactions between paclitaxel and cisplatin in female Wistar rats

Chiueh, C.C.; Chock, P.B.; Andoh, T., 2002 :
Neuroprotective mechanism of cyclic gmp

Nordberg, Agneta, 2001:
Neuroprotective mechanisms as treatment strategy in Alzheimers disease

Nieber, K., 2000:
Neuroprotective mechanisms of adenosine A1 and A3 receptors

Mahanthappa, Nagesh, K., 2004:
Neuroprotective methods and reagents

Shashoua, Victor, E., 2001:
Neuroprotective peptides and uses thereof

Brenneman, D.E.; Spong, C.Y.; Hauser, J.; Gozes, I., 2000:
Neuroprotective peptides prevent neuronal and embryonic death

Brenneman, D.E.; Hauser, J.; Gozes, I., 2000:
Neuroprotective peptides that exhibit both synergistic and non-chiral characteristics in dissociated cerebral cortical test cultures

Kamenka, J.M.rc; Michaud, M.; Drian, M.J.anne; Vignon, J.; Privat, A., 1999:
Neuroprotective pharmaceutical composition containing stereoisomers of arylcyclohexylamines

Marangos, P.J.; Sullivan, B.W.; Wiemann, T.; Danks, A.M.; Sragovicz, M.; Makings, L.R., 2000:
Neuroprotective poly-guanidino compounds which block presynaptic N and P/Q calcium channels

Koelker, S.; Ahlemeyer, B.; Krieglstein, J.; Hoffmann, G.F., 2000:
Neuroprotective potency of the radical scavengers alpha-tocopherol and melatonin in glutaric aciduria type I

Stutzmann, J-Marie.; Mary, V.; Wahl, F.; Grosjean-Piot, O.; Uzan, Aé.; Pratt, J., 2002:
Neuroprotective profile of enoxaparin, a low molecular weight heparin, in in vivo models of cerebral ischemia or traumatic brain injury in rats: a review

Haberman, F.N.; Greig, N.; Yu, Q.; Guo, Z.; Mattson, M.P., 2003:
Neuroprotective properties of analogs of uric acid and creatine

Lutz, B.; Marsicano, G.; Moosmann, B.; Hermann, H.; Behl, C., 2001:
Neuroprotective properties of cannabinoids in vitro Role of the cannabinoid receptor CB1

Inestrosa, N.C.; Chacon, M.; Barria, M.I.; Varela Nallar, L.; Opazo, C., 2002:
Neuroprotective properties of copper binding fragments of amyloid precursor protein and Prion

Camins, A.; Verdaguer, E.; Garcia Jorda, E.; Jimenez, A.; Canudas, A.M.; Pallas, M., 2002:
Neuroprotective properties of cyclin-dependent kinases inhibitors

Mitchell, C.K.; Bishop, J.J.; Feldman, R.M., 2000:
Neuroprotective properties of l-betaxolol on isolated retinal ganglion cells

Ito, H.; Watanabe, Y.; Isshiki, A.; Uchino, H., 1999:
Neuroprotective properties of propofol and midazolam, but not pentobarbital, on neuronal damage induced by forebrain ischemia, based on the GABAA receptors

Plaisant, F.; Dommergues, M.A.iette; Spedding, M.; Gressens, P., 2003:
Neuroprotective properties of tianeptine against neonatal excitotoxic, brain lesions Effects of cytokines

Sfaello, I.M.; Arzimanolgou, A.; Gressens, P., 2003:
Neuroprotective properties of topiramate in a mouse model of neonatal excitotoxic brain lesions

Busceti, C.L.; Battaglia, G.; Biagioni, F.; Fornai, F.; Cicirata, F.; Bovolin, P.; Bruno, V.; Ruggieri, S.; Nicoletti, F., 2003:
Neuroprotective role for mGLu2/3 metabotropic glutamate receptors in the MPTP model of parkinsonism in mice

Maheswari, S.L.; Murali, R.V.nkatakrishna, 2004:
Neuroprotective role of Centella asiatica Linn on aluminium-induced brain cholinotoxicity in Wistar albino rats

Sun, H.S.; Fu, Y.; Feng, Z.P.; Miki, T.; Seino, S.; Lu, Y.; French, R.J., 2003:
Neuroprotective role of KATP channels in hippocampus during experimental ischemia

Moochhala, S.; Teng, C.H.; Khanna, S.; Shirhan, M.; Greengrass, C.; Lu, J., 2000:
Neuroprotective role of aminoguanidine in behavioral changes following blast injury

Opole, R.W.ngechi; Mutembei, R.K.nyamu; Opole, I.O.wel; Fallon, J.H., 2001:
Neuroprotective role of epigallocatechin gallate and vitamin B12 in rodent brain

Lee, S.J.; Li, C.J.; Mcewen, B.S., 1999:
Neuroprotective role of estrogen following NMDA-induced toxicity in primary hippocampal cultures

Dluzen, D.E.; McDermott, J.L., 2000:
Neuroprotective role of estrogen upon methamphetamine and related neurotoxins within the nigrostriatal dopaminergic system

Chang, E.F.; Igarashi, T.; Wong, R.J.; Vreman, H.J.; Stevenson, D.K.; Noble, L.J., 2001:
Neuroprotective role of heme oxygenase-2 in traumatic brain injury

Williams, S.C.R.; Meldrum, B.S.; Pratt, G.D.; Barnes, J.C.; Lynch, L.A., 2000:
Neuroprotective role of lamotrigine in pilocarpine induced status epilepticus model

Sala, F.; Niimi, Y.; Berenstein, A.; Deletis, V., 2001 :
Neuroprotective role of neurophysiological monitoring during endovascular procedures in the spinal cord

Sommese, B.; Fallon, J., 2001:
Neuroprotective role of transforming growth factor alpha in the rodent nigrostriatal system

Fontaine, V.; Fuchs, C.; Hannoteau, N.; Eisel, U.; Sahel, J.; Dreyfus, H., 2000:
Neuroprotective role of tumor necrosis factor alpha in the retina following ischemia

Nakajima, K.; Kohsaka, S., 2002:
Neuroprotective roles of microglia in the central nervous system

Riepe, Matthias, W., 1999:
Neuroprotective strategies against cellular hypoxia

Alexi, T.; Borlongan, C.V.; Faull, R.L.; Williams, C.E.; Clark, R.G.; Gluckman, P.D.; Hughes, P.E., 2000:
Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases

Mandel, S.; Grünblatt, E.; Riederer, P.; Gerlach, M.; Levites, Y.; Youdim, M.B.H., 2003:
Neuroprotective strategies in Parkinson's disease : an update on progress

Youdim, M.B.H.; Krishna, G.; Chiueh, C.C., 1999:
Neuroprotective strategies in Parkinsons disease and Huntingtons chorea MPTP- and 3-NPA-induced neurodegeneration as models

Brundin, P.; Kaminski Schierle, G.S., 2000:
Neuroprotective strategies in neural grafting

Hoelen, D.; Peeters, C.; Van Bel, F.; Groenendaal, F.; Bar, D., 2001:
Neuroprotective strategies in organotypical cultured hippocampal slices of 8-day-old rats during and after oxygen glucose deprivation

Alanine, A.; Buettelmann, B.; Neidhart, M.P.ule Heitz; Jaeschke, G.; Pinard, E.; Wyler, R., 2002:
Neuroprotective substituted piperidine compounds with activity as NMDA NR2B subtype selective antagonists

Liang, C.L.ong; Yang, L.C.eng; Lu, K.; Hsu, H.C.en; Cho, C.L.ng; Chen, S.D.r; Huang, H.Y.ng; Chen, H.J.ng, 2003:
Neuroprotective synergy of N-methyl-D-aspartate receptor antagonist and protein synthesis inhibitor on spinal cord ischemia-reperfusion injury in rats

Simon, D.K.; Standaert, D.G., 1999:
Neuroprotective therapies

Goldstein, L.B., 2004:
Neuroprotective therapy for acute ischaemic stroke: down, but not out

Gusev, E.I.; Skvortsova, V.I., 2002:
Neuroprotective therapy for ischemic stroke II Secondary neuroprotection

Gusev, E.I.; Skvortsova, V.I., 2002:
Neuroprotective therapy of ischemic stroke I Primary neuroprotection

Pineiro, Jose Luis Castro, 2000:
Neuroprotective use of triazolo-pyridazine derivatives

He, X.; Shiosaka, S.; Yoshida, S., 2000:
Neuropsin is induced in oligodendrocytes after injury to the CNS

Mcwhirter, E.; Urowitz, M.; Rakowski, H.; Gladman, D., 2001:
Neuropsychiatric SLE Prevalence of cardiac valvular disease

Ducuing, F.; LeHeuzey, M.F.; Rouyer, V.; Mouren-Simeoni, M.C., 2004:
Neuropsychiatric abnormalities and continuous spikes and waves during slow sleep syndrome: a case report

Trimble, M.R.; Mula, M.; Liu, R.; Sander, L., 2003:
Neuropsychiatric adverse events in patients with epilepsy treated with levetiracetam

Boller, F.; Ganansia-Ganem, A.; Lebert, F.; Pasquier, F.; Petain, M.H.; Deschanel, P., 1999:
Neuropsychiatric afflictions of modern French presidents: Marechal Henri-Philippe Petain and Paul Deschanel

Cummings, J.L.; Litvan, I., 2000:
Neuropsychiatric aspects of corticobasal degeneration

Caballero, J.; Koranyi, K.I.; Brady, M.T.; Nahata, M.C., 2003:
Neuropsychiatric assessment in children with human immunodeficiency virus

Ballard, C.G.; Thomas, A., 2003:
Neuropsychiatric co-morbidity in dementia with and without movement disorders

Estrada, G.; Wildrick, D.; Pranzatelli, M., 2002:
Neuropsychiatric complications of levetiracetam in children with epilepsy

Frisoli, A.Jr; D'amorim, A.B.; Szejnfeld, V.L.; Vieira, J.G.H.; Ramos, L.R., 1999:
Neuropsychiatric disorders and osteoporosis in elderly patients with parathyroid adenoma and normal iPTH Report of two cases

Tost, H.; Schmitt, A.; Brassen, S.; Wendt, C.S.; Braus, D.F., 2004:
Neuropsychiatric facets of Huntingtons disease Report of two cases and review of the literature

Dunaway, L.A.; Como, P.G.; Moxley, R.T.; Barbieri, C.A.; Thornton, C.A.; Buhler, J.M.; Damaske, S.D., 2000:
Neuropsychiatric findings in myotonic dystrophy

Jeong, Y.S.ong; Bae, Sang Cheol; Jung, J.H.n; Uhm, Wan Sik; Seo, Jeong Cheol; Kim, Tae Hwan; Jun, Jae Bum; Jung, Sung Soo; Lee, I.H.ng; Yoo, Dae Hyun; Kim, Seong Yoon, 1999:
Neuropsychiatric lupus syndrome profile according to new ACR nomenclature and case definitions and its association with damage The Korean Hanyang Lupus Cohort

Brey, R.L.; Holliday, S.L.; Saklad, A.; Navarrete, M.G.; Valdez, C.; Escalante, A.; Del Ricon, I.; Rhine, C.R.; Harris, M.; Mitchell, B., 2001:
Neuropsychiatric lupus syndromes Prevalence using standardized definitions

Vaccaro, F.; Bernabei, A.; Laviano, A.; Gubitosi, G.; Giorgi, A.; Pace, F.; Fanelli, F.R.ssi, 2000:
Neuropsychiatric manifestation in primary antiphospholipid syndrome

Serrano, M.; Martins, C.; Pérez-Dueñas, Bén.; Gómez-López, L.; Murgui, E.; Fons, C.; García-Cazorla, A.; Artuch, R.; Jara, F.; Arranz, Jé.A.; Häberle, J.; Briones, P.; Campistol, J.; Pineda, M.; Vilaseca, M.A., 2010:
Neuropsychiatric manifestations in late-onset urea cycle disorder patients

Egger, C.; Sepp, N.; Benke, T.; Berger, T., 2001:
Neuropsychiatric manifestations in systemic lupus erythematosus

Perini, G.; Chemello, L.; Mapelli, D.; Bernardinello, E.; Del Piccolo, F.; Bergamelli, C.; Costanzo, R.; Bergamaschi, F.; D.T.ni, E.; Musto, C.; Gatta, A.; Umilta, C.; Alberti, A.; Amodio, P., 2001:
Neuropsychiatric monitoring of interferon treatment in viral hepatitis

Colebunders, R.; Hilbrands, R.; De Roo, A.; Pelgrom, J., 2002:
Neuropsychiatric reaction induced by abacavir

Belville Robertson, T.L.; Brown, K.A.; Moonka, D.K.; Mahr, G.; Clemensen, L.R.; Lucas, M.B.; Eshelman, A.K., 2001:
Neuropsychiatric status of 100 naive chronic hepatitis C patients ready to start interferon-based treatment

Brinkmann, E.; Kaul, G.; Zeller, H.J. , 2000:
Neuropsychiatric symptoms at low-level exposure to styrene

Alvarez, A.; Laredo, M.; Couceiro, V.; Fernandez Novoa, L.; Sampedro, C.; Cacabelos, R.; Vargas, M.; Aleixandre, M., 2003:
Neuropsychiatric symptoms in APOE genotyped Alzheimers disease patients Contributions to diagnosis and prognosis of the disease

Assal, Fédéric.; Cummings, J.L., 2002:
Neuropsychiatric symptoms in the dementias

Sibbitt, W.L.; Jung, R.E.; Brooks, W.M., 1999:
Neuropsychiatric systemic lupus erythematosus

Stojanovich, L.; Stojanovich, R.; Dzjolich, E.; Stefanova, E.; Kostich, V.; Kozich, D.; Savich, M., 2001:
Neuropsychiatric systemic lupus erythematosus A prospective study

Ikuta, K.; Kamitani, W.; Ono, E.; Kobayashi, T.; Taniyama, H.; Tomonaga, K., 2002:
Neuropsychiatric-like disorders in transgenic mice expressing Borna disease virus phosphoprotein in the CNS

Pauli, E.; Pickel, S.; Schulemann, H.; Buchfelder, M.; Stefan, H., 1999:
Neuropsychologic findings depending on the type of the resection in temporal lobe epilepsy

Perdomo, E.; Markham, A.; Aura, C.; Kutchma, T.; Perez, C.; Siem, J.; Stanton, M., 2004:
Neuropsychological Assessment and Electroencephalographic Monitoring During Variable Methods of Teaching

Cavanagh, J.; Van Beck, M.; Muir, W.; Blackwood, D., 2000:
Neuropsychological abnormalities in euthymic bipolar patients A case control study

Gyato, K.; Wray, J.; Huang, Z.J.; Yudkoff, M.; Batshaw, M.L., 2003:
Neuropsychological alterations in women with partial ornithine transcarbamylase deficiency

Del Piccolo, F.; Sacerdoti, D.; Amodio, P.; Bombonato, G.C.; Marchetti, P.; Bolognesi, M.; Gatta, A., 1999:
Neuropsychological and EEG alterations of cirrhosis Role of portal-systemic shunt and portal hypoperfusion

Santos, S.; Casadevall, T.; Tejero, C.; Rios, C.; Lopez, E.; Larrode, P.; Iniguez, C.; Pascual, L.F.; Garces, M.; Fabre, O.; Morales, F., 2002:
Neuropsychological and Neuroimaging findings in vascular dementia and Alzheimers disease

Bowler, R.M.; Smith, M.; Schwarzer, R.; Perez Arce, P.; Kreutzer, R., 2000:
Neuropsychological and academic characteristics of Mexican-American children A longitudinal field study

Boyle, P.A.; Au, R.; Beiser, A.; Kelly Hayes, M.; Kase, C.; Wolf, P.A., 2003:
Neuropsychological and functional outcomes following stroke Findings from the Framingham Study

Desrocher, M.; Rovet, J.; Noseworthy, M.; Perlman, K.; Laughlin, S.; Gates, L.; Rivera, M.; Foroughe, M., 2003:
Neuropsychological and neuroimaging evidence of hippocampal damage in Type I diabetes A pilot investigation

Mochizuki, S., 2004:
Neuropsychological and neuroimaging studies of 'theory of mind': a review

Senzolo, M.; Amodio, P.; D'aloiso, M.C.; Fagiuoli, S.; Del Piccolo, F.; Burra, P., 2004:
Neuropsychological and neurophysiological evaluation in patients with liver cirrhosis and minimal hepatic encephalopathy

Sauerwein, H.C.; Lassonde, M.; Revol, O.; Cyr, F.; Geoffroy, G.; Mercier, C., 2001:
Neuropsychological and psycho-social consequences of corpus callosotomy

Cooke, D.; Lunn, S.; Weller, I.; Harrison, M.; Newman, S., 2000:
Neuropsychological and psychological changes with disease progression

Besteiro, J.L.; Lemos, S.; Muniz, J., 2002:
Neuropsychological and psychophysiological correlates of DSM-IV personality disorders Gender comparisons

Manning, E.L.; Sundaram, M.; Doughty, A.; Nakase Thompson, R.; Johnson, S., 2001:
Neuropsychological and psychosocial outcome after temporal lobectomy for intractable seizure

Vercelletto, M.; Belliard, S.; Wiertlewski, S.; Venisse, T.; Magne, C.; Duyckaerts, C.; Damier, P., 2003:
Neuropsychological and scintigraphic aspects of frontotemporal dementia preceding amyotrophic lateral sclerosis

Casse Perrot, C.; Wolf, M.; Dravet, C., 2001:
Neuropsychological aspects of Severe Myoclonic Epilepsy in Infancy

Gigi, A.; Kahana, E.; Vakil, E.; Hadar, U.; Prohovnik, I., 1999:
Neuropsychological assessment in early Creutzfeldt-Jakob disease

Reynolds, C.R.; Mayfield, J.W., 1999:
Neuropsychological assessment in genetically linked neurodevelopmental disorders

Dantas Correa, E.B.; Correa Neto, Y.; Mattos, A.A.; Dantas, W., 2001:
Neuropsychological assessment of attention in nonalcoholic chronic hepatic disease patients without hepatic encephalopathy

Tagaris, G.A.; Koulousakis, A.; Visviki, T.; Fakas, N.; Heilakos, G.; Bozi, M.; Karageorgiou, C., 2001:
Neuropsychological assessment of cognitive functions after subthalamic deep brain stimulation for Parkinsons disease

Vaskov, T.; Dzonov, I.; Pashu, M.; Kedeva, D.; Cvetkovska, E.; Cuculovska, J., 2004:
Neuropsychological assessment of memory, attention and concentration in patients with epilepsy treated with lamotrigine

Wilken, J.A.; Kane, R.L.; Sullivan, C.L.; Wallin, M.T.; Usiskin, J.B.; Quig, M.E.; Simsarian, J.; Saunders, C.; Kerr, D.; Mandler, R.; Crayton, H.; Fuchs, K.; Reeves, D., 2003:
Neuropsychological assessment of multiple sclerosis patients The construct validity of computerized testing 12 months into treatment

Wilken, J.A.; Kane, R.L.; Sullivan, C.L.; Wallin, M.T.; Usiskin, J.B., 2002:
Neuropsychological assessment of multiple sclerosis patients The predictive validity of computerized testing

Walton, N.H.; Goodsman, C.; Mccarter, R.; Sandeman, D.R.; Bird, J.M.; Lewis, T.L.; Renowden, S.R., 1999:
Neuropsychological change scores following super-selective, image-guided surgery for the relief of intractable epilepsy

Kolk, A.; Talvik, T.; Laine, G., 2004:
Neuropsychological changes in children with newly diagnosed focal epilepsy before and after one year antiepileptic treatment a follow-up study

Adams, J.; Baer, S.; Gavin, J.A.L.; Janulewicz, P.A.; Meyer, E.; Lammer, E.J., 2001:
Neuropsychological characteristics of children embryonically exposed to isotretinoin Outcome of age 10

Swillen, A.; Vandeputte, L.; Cracco, J.; Devriendt, K.; Fryns, J.P., 1999:
Neuropsychological characteristics of children with VCFS Evidence for a non-verbal learning disability?

Lee, S.A.m; Yim, S.B.n; Lee, S.K.um; Kang, J.K.o; Yoo, H.J.ng, 2001:
Neuropsychological characteristics of mesial temporal lobe epilepsy Lesion laterality-sex interaction

Lopez, O.L.; Becker, J.T.; Jagust, W.J.; Fitzpatrick, A.; Carlson, M.C.; DeKosky, S.T.; Breitner, J.; Lyketsos, C.G.; Jones, B.; Kawas, C.; Kuller, L.H., 2005:
Neuropsychological characteristics of mild cognitive impairment subgroups

Weissenborn, K.; Ennen, J.C.; Schomerus, H.; Rückert, N.; Hecker, H., 2001 :
Neuropsychological characterization of hepatic encephalopathy

Sano, M.C.; Rho, T.H.; Polanco, Y.; Kwan, A.; Martin, B.; Piomelli, S.; D.V.vo, D.C., 1999:
Neuropsychological consequences of clinically silent MRI abnormalities in sickle cell disease A prospective study

Saint Cyr, J.A.; Trepanier, L.L., 2000:
Neuropsychological considerations in movement disorder surgery

Welzel, H.; Ende, G.; Hermann, D.; Walter, S.; Weber Fahr, W.; Heinz, A.; Mann, K., 2003:
Neuropsychological correlates of MR spectroscopic changes in chronic alcoholic patients

Ficek, S.K.F.eming; Mathalon, D.H.; Faustman, W.O.; Moses, J.A.Jr; Pfefferbaum, A.; Ford, J.M., 2000:
Neuropsychological correlates of electrophysiological functioning in schizophrenia

Haltiner, A.M.; Rostad, S.; Kraemer, D.; Wyler, A.R.; Hermann, B.P.; Vossler, D.G., 2001:
Neuropsychological correlates of lateral temporal lobe gliosis and hippocampal sclerosis in left temporal lobe epilepsy

Ha, T.H.; Kwon, J.S.; Roh, K.S.; Park, H.S.; Kim, M.S., 2003:
Neuropsychological correlations of obsessive-compulsive disorder symptom dimensions

Noeker, M.; Haverkamp, F., 2003:
Neuropsychological deficiencies as a mediator between CNS dysfunction and inattentive behaviour in childhood epilepsy

Skeel, R.L.; Johnstone, B.; Yangco, D.T.; Walker, S.E.; Komatireddy, G.R., 2000:
Neuropsychological deficit profiles in systemic lupus erythematosus

Majer, M.; Modell, S.; Holsboer, F.; Zihl, J., 2003:
Neuropsychological deficits and long-term outcomes in patients with affective disorders

Schaub, A.; Wolf, B.; Charypar, M.; Moeller, H.J., 2000:
Neuropsychological deficits and negative symptoms in patients with first-episode schizophrenia

Stott, H.D.; Tivis, R.D.; Nixon, S.J., 1999:
Neuropsychological deficits in alcoholics as a function of chronicity

Daum, I.; Snitz, B.E.; Ackermann, H., 2001:
Neuropsychological deficits in cerebellar syndromes

Salmond, C.H.; Vargha Khadem, F.; Gadian, D.G., 2001:
Neuropsychological deficits in children with autism are consistent with medial temporal lobe pathology

Ballard, C.; Stephens, S.; McLaren, A.; Wesnes, K.; Kenny, R.Anne.; Burton, E.; O'Brien, J.; Kalaria, R., 2002:
Neuropsychological deficits in older stroke patients

Schmidtke, K.; Huell, M., 2002:
Neuropsychological diagnosis of vascular dementia

Sheline, Y.I.; Doraiswamy, M.; Barch, D.M.; Garcia, K.S.; Steffens, D.; Krishnan, K.R., 2003:
Neuropsychological differences in treatment responders versus nonresponders in late life depression

Schmidtke, K.; Hüll, M., 2002:
Neuropsychological differentiation of small vessel disease, Alzheimer's disease and mixed dementia

Flöel, A.; Lohmann, H.; Knecht, S., 2002:
Neuropsychological disorders in amyotrophic lateral sclerosis

Tanaka, K.; Tokui, T.; Suzuki, T.; Shimamoto, A.; Kondo, C.; Onoda, K.; Shimono, T.; Yada, I.; Matsumura, K.; Takeda, K., 2000:
Neuropsychological dysfunction after cardiac surgery Preoperative evaluation of cerebral perfusion reserve using TC-99m ECD SPECT enhanced by axctazolamide

Yoshioka, M.; Matsumoto, S.; Kuroki, S., 1999:
Neuropsychological effect of temporal lobe resection in children with intractable epilepsy

Cukiert, M.; Caner Cukiert, A.R.; Cukiert, A., 2001:
Neuropsychological effects of anterior callosal sections

Tomkinson, S.; Stephens, R., 2003:
Neuropsychological effects of chronic low-level mercury exposure released from mercury amalgam fillings

Welzel, G.; Steinvorth, S.; Wenz, F.; Fuehler, M.; Hacke, W.; Debus, J.; Wannenmacher, M., 2000:
Neuropsychological effects of fractionated, stereotactic radiation therapy in patients with meningiomas

Halpern, J.H.; Pope, H.G.Jr.; Sherwood, A.; Hudson, J.I.; Yurgelun Todd, D., 2002:
Neuropsychological effects of long-term hallucinogen use versus alcoholism in Native Americans Cultural limitations of tests

Greenwald, R.M.; Mecham, M.D.; Shumlimson, A.; Smith, J.W.; Nelson, K.; Johnson, S.C., 1999:
Neuropsychological effects of repeated head impacts in aerial ski jumping

Becker, L.; New, M., 2002:
Neuropsychological effects of vertically acquired HIV infection in children A longitudinal perspective

Tivis, R.D.; Nixon, S.J.; Phillips, M.E.; Tivis, L.J.; Varner, J.; Rohrbaugh, J., 1999:
Neuropsychological efficiency in women as related to age and level of alcohol consumption

Lopez, C.; Jimenez, M.; Moreno, S.; Fernandez, S.; Robles, J.I.; Motta, M.; Garcia, J.; Palacio, C.; Lopez, M.; Ruiz Linares, A.; Ospina Duque, A., 2003:
Neuropsychological endophenotype of patients with bipolar mood disorder I

Levy, R., 2000:
Neuropsychological evaluation A useful clinical tool in the diagnosis of neurodegenerative diseases

Dubois, B.; Beato, R.; Villalpando, J.M., 2003:
Neuropsychological evaluation can contribute to the diagnosis of motion diseases

Silva, M.T.T.; Araujo, A.Q.C.; Oliveira, A.L.A.; Mattos, P.; Campos, A.A.; Luiz, R.R., 2001:
Neuropsychological evaluation in HTLV-I-associated myelopathy

Santiago Gomez, R.; Dominguez Salgado, M.; Diaz Obregon Santos, M.C.; Guede, H.B.thal; Leon, M., 2004:
Neuropsychological evaluation in an epilepsy unit results of two years from initial onset with topiramate treatment as first choice antiepileptic drug

Kobayashi, E.; Leone, A.A.A.; Damasceno, B.P.; Lopes Cendes, I.; Li, L.M.; Cendes, F., 2002:
Neuropsychological evaluation in patients with familial mesial temporal lobe epilepsy

Silva, M.T.lius Teixeira; Araujo, A.Q.eiroz Campos; Mattos, P.; Campos, A.A.fano; Luiz, R.R.ggio, 2001:
Neuropsychological evaluation of HTLV-I infected patients

Lukezic, M.; Pozzobon, G.; Forlani, S.; Somajni, F.; Lenti, C.; D.N.tale, B.; Chiumello, G.; D.A.gelis, R., 2000:
Neuropsychological evaluation of children with isolated growth hormone deficiency

Moretti, R.; Torre, P.; Antonello, R.M.; Cazzato, G., 2001:
Neuropsychological evaluation of late-onset, post-radiotherapy encephalopathy

Denburg, N.L.; Bechara, A.; Tranel, D.; Hindes, A.R.; Damasio, A.R., 1999:
Neuropsychological evidence for why the ability to decide advantageously weakens with advancing age

Buchanan, T.W.; Tranel, D.; Adolphs, R., 2003:
Neuropsychological evidence that the human amygdala plays a key role in olfactory memory

Ala, T.A.; Elble, R.J., 2002:
Neuropsychological features help to distinguish dementia with Lewy bodies from Alzheimer disease

Banwell, B.L.; Anderson, P.E., 2002:
Neuropsychological features of pediatric Multiple Sclerosis

Byars, A.W.; Degrauw, T.J.; Caffrey, H.H.; Fastenau, P.S.; Egelhoff, J.C.; Mathews, V.P.; Dunn, D.W.; Austin, J.K., 2002:
Neuropsychological findings at first recognized seizure Comparison of children with and without abnormal magnetic resonance imaging

Chandler, K.; Moffett, M.; Clayton Smith, J.; Baker, G., 2002:
Neuropsychological findings in a group of UK patients with Cohen syndrome

Reed, B.R.; Mungas, D.; Kramer, J.H.; Betz, B.; Ellis, W.; Vinters, H.; Zarow, C.; Jagust, W.J.; Chui, H.C., 2002:
Neuropsychological findings in autopsy-confirmed vascular dementia

Jocic Jakubi, B.; Jovanovic, M.; Stankovic Jankovic, D.; Brankovic Sreckovic, V., 2004:
Neuropsychological findings in children with focal epilepsy

Tuulio Henriksson, A.; Partonen, T.; Arajarvi, R.; Juvonen, H.; Haukka, J.; Cannon, T.; Hovatta, I.; Paunio, T.; Ekelund, J.; Varilo, T.; Peltonen, L.; Lonnqvist, J., 2000:
Neuropsychological findings in schizophrenia patients and their first-degree relatives

Donnet, A.J.; Schmitt, A.; Dufour, H.; Azulay, J.P.ilippe; Mesure, S., 2001 :
Neuropsychological follow-up of 10 adult patients after surgery for normal pressure hydrocephalus

George, T.P.; Termine, A.; Vessicchio, J.C.; Wexler, B.E.; Kosten, T.R., 2000:
Neuropsychological function during smoking abstinence in schizophrenia

George, T.P.; Vessicchio, J.; Termine, A.; Pepper, T.; Wexler, B.E.; Kosten, T.R., 2000:
Neuropsychological function during smoking cessation in schizophrenia

Waterloo, K.; Omdal, R.; Husby, G.; Mellgren, S.I., 2001:
Neuropsychological function in SLE A 5-year longitudinal study

Como, P.G., 2001:
Neuropsychological function in Tourette syndrome

Glass, J.M.; Nigg, J.T.; Puttler, L.I.; Adams, K.M.; Wong, M.M.; Fitzgerald, H.E.; Zucker, R.A., 2002:
Neuropsychological function in adolescent boys from high-risk families Deficits in response inhibition and complex processing speed

Ringman, J.M.; Rodriguez, Y.; Chavez, M.; Diaz Olavarrieta, C.; Paz, F.; Murrell, J.; Kawas, C.H., 2003:
Neuropsychological function in pre-clinical presenilin-1 mutation carriers

Bandstra, E.S.; Morrow, C.E.; Accornero, V.H.; Johnson, A.L.; Ofir, A.Y.; Xue, L.; Anthony, J.C., 2002:
Neuropsychological function in prenatally cocaine-exposed children

Roeschl Heils, A.; Bledowski, C.; Elger, C.E.; Heils, A.; Helmstaedter, C., 2002:
Neuropsychological functioning among 32 patients with temporal lobe epilepsy and their discordant siblings

Fastenau, P.S.; Johnson, C.S.; Byars, A.W.; Austin, J.K.; Dunn, D.W.; Perkins, S.M., 2003:
Neuropsychological functioning at first recognized seizure Comparisons between seizure types

Fastenau, P.S.; Caffrey, H.H.; Byars, A.W.; Austin, J.K.; Dunn, D.W.; Perkins, S.M., 2002:
Neuropsychological functioning at first recognized seizure Comparisons with sibling controls and effects of prior unrecognized seizures

Monastero, R.; Triolo, G.; Pipia, C.; Lopez, G.; Mannino, M.; Francolini, M.; Ferrante, A.; Camarda, L.K.C.; Camarda, R., 2000:
Neuropsychological functioning in Behcets disease

Smith, M.L.u; Elliott, I.M.; Lach, L.M., 1999:
Neuropsychological functioning in children with intractable epilepsy Comparison of surgical and non-surgical candidates

Westervelt, H.James.; McCaffrey, R.J., 2002:
Neuropsychological functioning in chronic Lyme disease

Hampson, E., 2003:
Neuropsychological functioning in healthy postmenopausal women taking long-term estrogen replacement

Verzijl, H.T.F.M.; Van Es, N.; Berger, H.J.C.; Padberg, G.W.; Van Spaendonck, K.P.M., 2003:
Neuropsychological functioning in mobius syndrome A population-based survey

Konings, G.; Gielissen, M.; Schreuder, K., 2001:
Neuropsychological functioning in patients with Obstructive Sleep Apnea Syndrome, treated with CPAP

Verrill, M.; Rodgers, J.; Morse, R.; Kendell, K.; Wesnes, K.; Marshall, I.; Manktelow, T., 2003:
Neuropsychological functioning in women following adjuvant treatment for breast cancer

Tapert, S.F.; Brown, S.A., 1999:
Neuropsychological functioning of youth Effects of alcohol abuse and conduct disorder

Annoni, J.M.rie; Gramigna, S.; Staub, F.; Carota, A.; Bogousslavsky, J., 2001:
Neuropsychological impairment after pure lateral thalamic strokes

Barry, D.; Bates, M.E.; Morgenstern, J.; Cisler, R.; Tonigan, J.S.; Voelbel, G.; Fals Stewart, W., 2003:
Neuropsychological impairment and social support for abstinence

Mussell, M.; Rossol, S.; Stober, T.; Flor, H.; Singer, M.V., 2002:
Neuropsychological impairment in patients with hepatitis C virus infection during therapy with Interferon-alpha

Ondze, B.; Espa, F.; Szwarcberg, G.; Sanyas, I.; Dauvilliers, Y.; Billiard, M.; Besset, A., 2000:
Neuropsychological impairment, sleep fragmentation and sleep disorders breathing

Cunha, P.J.; Nicastri, S.; Gomes, L.P.; Moino, R.M.; Peluso, M.A., 2004:
Neuropsychological impairments in crack cocaine-dependent inpatients: preliminary findings

Mizuno, M.; Kashima, H., 2002:
Neuropsychological investigation the effects of psychiatric rehabilit strategies for schizophrenia

Mazhitova, Z.K.; Kuanova, L.B., 1999:
Neuropsychological investigations in estimation of CNS functional disorders induced by environmental toxicant

Monterosso, J.; Ehrman, R.; Napier, K.; Obrien, C.P.; Childress, A.R., 2002:
Neuropsychological measures of ventromedial pre-frontal cortical functioning predict cue-reactivity

Matell, M.S.; Meck, W.H., 2000:
Neuropsychological mechanisms of interval timing behavior

Oyegbile, T.; Dow, C.; Seidenberg, M.; Bell, B.; Jones, J.; Woodard, A.; Rutecki, P.; Hermann, B., 2003:
Neuropsychological morbidity in chronic temporal lobe epilepsy

Quigg, M.; Barbaro, N.; Ward, M.; Laxer, K.D.; Epilepsy Radiosurgery Study Group, 2003:
Neuropsychological outcome 1 year after gamma knife radiosurgery for mesial temporal lobe epilepsy Preliminary findings

Lutz, M.T.; Helmstaedter, C.; Clussmann, H.; Schramm, J.; Elger, C.E., 2003:
Neuropsychological outcome after selective hippocampectomy with transsylvian versus transcortical approach A randomized prospective clinical Trial

Kaufmann, F.; Everts, R., 2004:
Neuropsychological outcome after stroke in childhood

Lehrner, J.; Czech, T.; Novak, K.; Serles, W.; Pataraia, E.; Bacher, J.; Olbrich, A.; Aull, S.; Leutmezer, F.; Groppel, G.; Deecke, L.; Baumgartner, C., 1999:
Neuropsychological outcome after temporal lobectomy

Wilde, M.C.; Plenger, P.; Brookshire, B.; Van Horn, G., 1999:
Neuropsychological outcome after unilateral posteroventral pallidotomy

Morris, P.G.; Wilson, J.T.L.; Teasdale, G.M., 2000:
Neuropsychological outcome at 8 years following traumatic brain injury

Brizzolara, D.; Brovedani, P.; Casalini, C.; Guerrini, R., 2001:
Neuropsychological outcome following prolonged febrile seizures associated with hippocampal sclerosis and temporal lobe epilepsy in children

Jambaque, I.; Mottron, L.; Chiron, C., 2001:
Neuropsychological outcome in children with West syndrome A human model for autism

Caravale, B.; Vicari, S.; Partigianoni, R.; Galiffa, S., 2003:
Neuropsychological outcome in low-birth-weight children at 3 to 4 years of age

Doss, R.C.; Gates, J.R.; Randa, J.H., 2002:
Neuropsychological outcome in multiple subpial transection

White, J.R.; Walczak, T.S.; Cox, C.M.; Arndt, R.C.; Leppik, I.E.; Rarick, J.O.; Maxwell, R.E.; Gumnit, R.J., 2001:
Neuropsychological outcome in older patients undergoing anterior temporal lobectomy

Hempel, A.; Risse, G.L.; Frost, M.D.; Ritter, F.J., 2001:
Neuropsychological outcome of dominant frontal topectomy in children and adolescents

Helmstaedter, C.; Lendt, M., 2001:
Neuropsychological outcome of temporal and extratemporal lobe resections in children

Smith, M.L.u; Elliott, I.M.; Lach, L., 2003:
Neuropsychological outcome two to four years after epilepsy surgery in children and adolescents

Bao, Y.; Tingus, K.; Ercoli, L.; Komo, S.; Bookheimer, S.; Small, G., 1999:
Neuropsychological performance as a function of APOE-epsilon4 status

Morrison, C.M.; Bayer, A.; Williams, J.; Owen, M.J.; Muir, J.L.; Handley, O.J., 2003:
Neuropsychological performance as a function of the apolipoprotein E gene and time a comparison between healthy eldery and first degree relatives of Alzheimers patients

Glass, J.M.; Puttler, L.I.; Zucker, R.A.; Nigg, J.T.; Poon, E.; Twitchell, G.R.; Adams, K.M.; Fitzgerald, H.E., 2001:
Neuropsychological performance in adolescent children of alcoholics

Shor Posner, G.; Campa, A.; Lecusay, R.; Wilkie, F.; Miguez, M.; Quesada, J.; Garcia, R.; Zhang, G.; Lai, S.; Baum, M.K., 1999:
Neuropsychological performance in relationship to selenium status in the Miami HIV-1 infected drug abusers study

Broderick, C.P.; Hsu, L.M.; Massoth, N.A., 1999:
Neuropsychological performance of MS patients with and without the use of Avonex

Beglinger, L.J.; Ahmed, S.; Derby, M.A.; Siemers, E.; Fastenau, P.S.; Crawford-Miller, J.; Shekhar, A.; Kareken, D.A., 2003:
Neuropsychological practice effects and change detection in people with schizophrenia

Luis, C.A.; Baker, W.W.; Loewenstein, D.A.; Hurwitz, D.; Bravo, M.; Luis, M.; Dunkley, M.; Perrota, L.; Crum, T.; Duara, R., 2002:
Neuropsychological predictors of conversion to dementia in subgroups of patients with mild cognitive impairment

Millani, R.; Schifano, F., 2000:
Neuropsychological problems associated with ecstasy use

Rhodes, S.M.; Coghill, D.R.; Matthews, K., 2003:
Neuropsychological profile and response to methylphenidate in girls with hyperkinetic disorder

Schrander Stumpel, C.T.R.M.; Van Der Vlugt, H.; Berndsen Peeters, K.J.; Curfs, L.M.G., 2001:
Neuropsychological profile in Kabuki syndrome

Campbell, L.E.isabet; Stevens, A.F.; Morris, R.; Karmiloff Smith, A.; Simonoff, E.; Owen, M.J.; Murphy, D.G.M.; Murphy, K.C., 2001:
Neuropsychological profile of children with Velo-cardio-facial syndrome

Aguilar Alonso, A.; Sanchez Lancis, E., 2002:
Neuropsychological profile of children with different dysfunctions and behavioral problems, by means of the NEPSY

Prichep, L.S.; Alper, K.; Tom, M.; Merkin, H.; Howard, B.; Kowalik, S.; Rosenthal, M.S., 2000:
Neuropsychological profile of cocaine-dependent subjects

Kuroda, M.M.; Zelko, F.A.; Southern, C.A.; Tomita, T.; Nordli, D.R.J., 2003:
Neuropsychological profiles after brain surgery in childhood

Engman, E.; Anderson Roswall, L.; Malmgren, K., 1999:
Neuropsychological profiles before and 2 years after epilepsy surgery

Hendriks, M.P.H.; Scholtes, F.B.J., 1999:
Neuropsychological profiles of 11 children with continuous spikes and waves during sleep ; A clinical follow-up

Brumm, V., 2002:
Neuropsychological profiles of adult subjects with early treated phenylketonuria

Schwarz, K.B.; Ichord, R.N.; Reimschisel, T.E.; Alford, M.K.; Barnes, Y.P.; Pulsifer, M., 2001:
Neuropsychological profiles of children with end-stage liver disease pre- and post transplant